www.TheFinancialMarketingGroup.com
Followers | 59 |
Posts | 2,197 |
Boards Moderated | 4 |
Alias Born | 04/28/2019 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How the mighty Litecoin has fallen. Key supports Broken.
It fells very much like we are sitting waiting for the inevitable to happen and we drop another $12 to the golden pocket.
The market sentiment has become extremely bearish and Bullish volume is no where in sight.
Defending the 200 EMA is now the priority but haven been tested already, 1 more push by the Bears and it will capitulate like all the levels before it.
Any reversal now will be difficult given the volume of resistance levels now in play.
US Government Bearishness put a temporary floor in BTC today LOL
t probably was not what the US Treasury Secretary imagined would happen when he took to live TV to lambaste Crypto Currencies, but somehow he managed to ignite a $600 reversal from a very critical low level. Thanks you Mr Steve Mnuchin.
It has given temporary relief to the bulls but the rally of the lows today has not been followed up by adequate volume to break important resistance levels.
There is still a very slight chance that a ABCDE correction is in play and the D is been formed, this is the optimistic outlook, while that CME gap still remains a possible deeper correction target.
US Government Bearishness put a temporary floor in BTC today LOL
t probably was not what the US Treasury Secretary imagined would happen when he took to live TV to lambaste Crypto Currencies, but somehow he managed to ignite a $600 reversal from a very critical low level. Thanks you Mr Steve Mnuchin.
It has given temporary relief to the bulls but the rally of the lows today has not been followed up by adequate volume to break important resistance levels.
There is still a very slight chance that a ABCDE correction is in play and the D is been formed, this is the optimistic outlook, while that CME gap still remains a possible deeper correction target.
GDET is our new subpenny crypto stock alert.+769% potential gain
=====================
GDET ( GD Entertainment & Technology, Inc.)
Alert Price: $0.0068
Goldman Price Target: $0.06
Goldman Small Cap Research Report
Website | Recent News
========================
Members,
Back in December, it seemed that bitcoin was headed for oblivion. But the death of the cryptocurrency has been greatly exaggerated.
During the past six months or so, bitcoin has surged from $3,100 to over $13,000.
Wall Street has a major crush on cryptocurrency markets that it just can't seem to get over. Stock investors look upon the massive gains earned by early Bitcoin and Ethereum investors with envy. They see the value in blockchain technology and distributed ledgers and want to get in on the action before the markets have fully priced in the impact that cryptocurrencies will have on the economy. While most investors are a bit weary to open up an account with a private cryptocurrency exchange like Binance or Coinbase, there are still plenty of opportunities to get exposure to cryptocurrencies in the public markets.
We have just identified an amazing opportunity to capitalize on the most recent crypto bull-run at under a penny per share.
Please turn your immediate attention to GD Entertainment And Technology (OTC: GDET).
This $0.0068 blockchain stock received a 6-cent price target from Goldman Small Cap Research, which is an upside of +782% from today's subpenny alert price.
GDET is the Top Pure Play on 2 of the Fastest Growing Industries
GDET, focuses on high growth industries to fulfill a diverse selection of premium products nationwide. The company currently has two subsidiaries: DreamCard and HyperDigital Technologies. DreamCard allows users to create a customizable debit or credit card using its state-of the-art online platform Dreamcard. cc . HyperDigital Technologies is the Cryptocurrency ATM sector of GDET and aims to secure multiple MSB, money services business, licenses in order to host ATM units throughout the country.
Subpenny Stocks = Big Moves
GDET has a history of seeing rapid gains in the short term. Just last month it hit over a penny when it was as low as $0.0055 at the end of April. The gain here was 100% in just a few days.
Earlier this year shares shares were as low as $0.0027 at the end of February and then hit $0.0229 in March for a Gain of Nearly 750% in Just a Few Weeks!
We are banking on another big move from GDET on Monday, as more and more investors look to cash in on the next crypto boom!
With all these bullish catalysts working in its favor, we see no reason why GDET can't once again move beyond $0.01.
Especially since the Company has recently made some big announcements that are sure to grab the attention of the Street.
The Company announced that they have engaged Forest Hill Electric to upgrade their cryptocurrency mining facility which includes the installation of additional ASIC Bitcoin Miners and ventilation systems.
At the end of May GDET announced that it had completed its migration to a new cryptocurrency mining pool and is running at full capacity.
The new mining pool is also fully integrated with major cryptocurrency exchanges, which means the user can seamlessly send and trade the cryptocurrency reward payouts in real time market conditions. With lesser transaction and payout times/restrictions, the flexibility of converting the cryptocurrency can become more favorable.
The $275 billion cryptocurrency market is continuing to experience a serious rally with bitcoin once again moving past $8,000.
GDET CEO Anil Idnani commented, “I am very proud to announce that my team was able to complete this migration on every one of our machines without any difficulties. We are already experiencing a higher total operating hashrate than the previous mining pool our machines were integrated with. The upgrade in firmware and new mining pool allows the operation to run at full capacity during this crypto rally and I look forward to seeing what new barriers Bitcoin and cryptocurrencies break next.”
The above actions by GDET could result in a massive influx of revenue in the very near future.
That being said, we have a feeling that GDET is going to be our next subpenny alert to deliver triple digit gains.
But don't just take our word for it, Goldman Small Cap Research recently slapped a $0.06 price target on this $0.0069 stock.
We just did the quick math, and that's an upside of over +782%!
About GD Entertainment and Technology
GD Entertainment & Technology, also known as GDET, focuses on high growth industries to fulfill a diverse selection of premium products nationwide. The company currently manufactures, wholesales, and markets a portfolio of blockchain/financial service-based products. GDET strives to become one of the premier Cryptocurrency mining facilities that is client-focused and dedicated to creating a new standard in the Blockchain space based on security and transparency. GDET has also developed a strong relationship with suppliers worldwide to ensure future purchasing. The company currently has two subsidiaries, DreamCard and HyperDigital Technologies, which both offer a selection of transactional-based products and services. DreamCard allows users to create a customizable debit or credit card using its state of the art online platform. HyperDigital Technologies is the Cryptocurrency ATM sector of GDET and aims to secure multiple MSB, money services business, licenses in order to host ATM units throughout the country.
Company Highlights
GDET’s HyperDigital Technologies subsidiary is setting the stage to secure multiple money services business licenses in order to host cryptocurrency ATM (or kiosk) units throughout the country during 2019. Once deployed, these units can generate high returns per transaction, regardless of crypto pricing changes. GDET also runs crypto mining operations in New Jersey.
An early stage player with a diversified revenue stream in high profile and high growth markets, we believe GDET offers considerable upside.
Recent Developments
GDET Announces Upgrade to Cryptocurrency Mining Facility
Earlier this month GDET announced is has engaged Forest Hill Electric to upgrade their cryptocurrency mining facility which includes the installation of additional ASIC Bitcoin Miners and ventilation systems.
GDET CEO , Anil Idnani, commented, “My team and company vision has always supported the longevity and worldwide integration of cryptocurrency. Not only have we seen a bullish spike in the market cap of cryptocurrency and strong support levels but also major announcements from companies like Facebook with the creation of their own currency, Libra. I am looking forward to work with Forest Hill Electric’s team once again to expand our facility and increase our Bitcoin hashrate.”
Management has already prepared the ASIC miners for immediate installation on site and is looking to upgrade the entire ventilation system with the purchase of additional, industrial-grade fans. Following the upgrade of the facility’s electric capacity, Forest Hill Electric was able to consult the Company on how to safely maximize the number of miners available for installation. At present, the Company is working to achieve the following near-term objectives:
Installation of brand new ASIC Bitcoin Miners
Installation of industrial-grade fans
Integrate the miners to increase overall hashrate
Engage third-party electricity providers to lower monthly power costs
Forest Hill Electric CEO Mike Fiore added, “My team is looking forward to upgrading this facility so that it can run at maximum capacity in a safe and controlled environment. We are also happy to announce that our company is officially working in house at the GDET mining facility, which will allow us to provide special attention to this project moving forward.”
GDET shareholders can expect new updates very soon as the Company continues to execute an aggressive phase of operational development and expansion.
Market Outlook:
Despite bitcoin pulling back after a colossal run in 2017, bitcoin enthusiasts still believe the cryptocurrency will be able to hit new highs consistently during the 2nd half of this year.
The $275 billion cryptocurrency market is continuing to experience a serious rally with bitcoin jumping over $13,000 once again.
Bitcoin , as well as blockchain (a transaction ledger that maintains identical copies across each member computer within a network), is being forecast as the Next Big Thing for the future.
For an idea of just how big blockchain may become, David Marcus, a vice president at Facebook , recently said he was stepping down from the board of directors at cryptocurrency exchange Coinbase. Instead he will be leading Facebook’s blockchain strategy. When you have the biggest social media company jumping on the blockchain bandwagon, it speaks in volumes of what hopes big companies have for this arena.
In 2017, the aggregate value of digital currencies, including bitcoin and ethereum , saw a jump of almost $600 billion, which in percentage terms was more than 3,300%. That’s a gain of 3,300% in only twelve months.
The share prices of semiconductor stocks such as NVIDIA , Advanced Micro Devices , and Taiwan Semiconductor Manufacturing Company, saw positive impacts in the last year as a result of seeing a strong demand from high performance computing like cryptocurrency mining.
(A report published by TrustNodes has revealed that Ethereum miners make almost $2.5 Billion on an annual basis!)
Famous Venture Capitalist Tim Draper once said that he thinks bitcoin will hit over $100,000. This is the man who said that Bitcoin will hit $10,000 in three years back in 2014. It hit almost $20,000 in 2017.
Draper has also responded to people questioning whether or not he will sell his bitcoin with this question: "Why would I sell the future for the past?"
Technical Analysis
As we mentioned above, GDET has a history of seeing rapid gains in the short term. Just last month, it hit over a penny when it was as low as $0.0055 at the end of April. The gain here was 100% in just a few days.
Earlier this year shares shares were as low as $0.0027 at the end of February and then hit $0.0229 in March for a Gain of Nearly 750% in Just a Few Weeks!
A move to $0.01 would show traders gains of up to +44.93%.
A move to $0.02 would show traders gains of up to +189.86%.
A move all the way to Goldman Small Cap Research's $0.06 target price would show traders gains of +782%!
The Bottom-Line
We love these subpenny alerts because even the smallest move can result in massive gains for traders.
Based on its past history, and our research, we believe that GDET could be our next subpenny alert to run-up for triple-digit gains.
Add it to the top of your watchlist immediately.
(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned here within, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated thirty five thousand dollars by ACN LLC to conduct a one day investor relations advertising and marketing campaign for GDET and 3000 Tradingview views. We have been previously compensated fifteen thousand dollars by ACN LLC to conduct a one-day investor relations advertising and marketing campaign for GDET on two seperate occasions-which have expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
GDET is our new subpenny crypto stock alert.+769% potential gain
=====================
GDET ( GD Entertainment & Technology, Inc.)
Alert Price: $0.0068
Goldman Price Target: $0.06
Goldman Small Cap Research Report
Website | Recent News
========================
Members,
Back in December, it seemed that bitcoin was headed for oblivion. But the death of the cryptocurrency has been greatly exaggerated.
During the past six months or so, bitcoin has surged from $3,100 to over $13,000.
Wall Street has a major crush on cryptocurrency markets that it just can't seem to get over. Stock investors look upon the massive gains earned by early Bitcoin and Ethereum investors with envy. They see the value in blockchain technology and distributed ledgers and want to get in on the action before the markets have fully priced in the impact that cryptocurrencies will have on the economy. While most investors are a bit weary to open up an account with a private cryptocurrency exchange like Binance or Coinbase, there are still plenty of opportunities to get exposure to cryptocurrencies in the public markets.
We have just identified an amazing opportunity to capitalize on the most recent crypto bull-run at under a penny per share.
Please turn your immediate attention to GD Entertainment And Technology (OTC: GDET).
This $0.0068 blockchain stock received a 6-cent price target from Goldman Small Cap Research, which is an upside of +782% from today's subpenny alert price.
GDET is the Top Pure Play on 2 of the Fastest Growing Industries
GDET, focuses on high growth industries to fulfill a diverse selection of premium products nationwide. The company currently has two subsidiaries: DreamCard and HyperDigital Technologies. DreamCard allows users to create a customizable debit or credit card using its state-of the-art online platform Dreamcard. cc . HyperDigital Technologies is the Cryptocurrency ATM sector of GDET and aims to secure multiple MSB, money services business, licenses in order to host ATM units throughout the country.
Subpenny Stocks = Big Moves
GDET has a history of seeing rapid gains in the short term. Just last month it hit over a penny when it was as low as $0.0055 at the end of April. The gain here was 100% in just a few days.
Earlier this year shares shares were as low as $0.0027 at the end of February and then hit $0.0229 in March for a Gain of Nearly 750% in Just a Few Weeks!
We are banking on another big move from GDET on Monday, as more and more investors look to cash in on the next crypto boom!
With all these bullish catalysts working in its favor, we see no reason why GDET can't once again move beyond $0.01.
Especially since the Company has recently made some big announcements that are sure to grab the attention of the Street.
The Company announced that they have engaged Forest Hill Electric to upgrade their cryptocurrency mining facility which includes the installation of additional ASIC Bitcoin Miners and ventilation systems.
At the end of May GDET announced that it had completed its migration to a new cryptocurrency mining pool and is running at full capacity.
The new mining pool is also fully integrated with major cryptocurrency exchanges, which means the user can seamlessly send and trade the cryptocurrency reward payouts in real time market conditions. With lesser transaction and payout times/restrictions, the flexibility of converting the cryptocurrency can become more favorable.
The $275 billion cryptocurrency market is continuing to experience a serious rally with bitcoin once again moving past $8,000.
GDET CEO Anil Idnani commented, “I am very proud to announce that my team was able to complete this migration on every one of our machines without any difficulties. We are already experiencing a higher total operating hashrate than the previous mining pool our machines were integrated with. The upgrade in firmware and new mining pool allows the operation to run at full capacity during this crypto rally and I look forward to seeing what new barriers Bitcoin and cryptocurrencies break next.”
The above actions by GDET could result in a massive influx of revenue in the very near future.
That being said, we have a feeling that GDET is going to be our next subpenny alert to deliver triple digit gains.
But don't just take our word for it, Goldman Small Cap Research recently slapped a $0.06 price target on this $0.0069 stock.
We just did the quick math, and that's an upside of over +782%!
About GD Entertainment and Technology
GD Entertainment & Technology, also known as GDET, focuses on high growth industries to fulfill a diverse selection of premium products nationwide. The company currently manufactures, wholesales, and markets a portfolio of blockchain/financial service-based products. GDET strives to become one of the premier Cryptocurrency mining facilities that is client-focused and dedicated to creating a new standard in the Blockchain space based on security and transparency. GDET has also developed a strong relationship with suppliers worldwide to ensure future purchasing. The company currently has two subsidiaries, DreamCard and HyperDigital Technologies, which both offer a selection of transactional-based products and services. DreamCard allows users to create a customizable debit or credit card using its state of the art online platform. HyperDigital Technologies is the Cryptocurrency ATM sector of GDET and aims to secure multiple MSB, money services business, licenses in order to host ATM units throughout the country.
Company Highlights
GDET’s HyperDigital Technologies subsidiary is setting the stage to secure multiple money services business licenses in order to host cryptocurrency ATM (or kiosk) units throughout the country during 2019. Once deployed, these units can generate high returns per transaction, regardless of crypto pricing changes. GDET also runs crypto mining operations in New Jersey.
An early stage player with a diversified revenue stream in high profile and high growth markets, we believe GDET offers considerable upside.
Recent Developments
GDET Announces Upgrade to Cryptocurrency Mining Facility
Earlier this month GDET announced is has engaged Forest Hill Electric to upgrade their cryptocurrency mining facility which includes the installation of additional ASIC Bitcoin Miners and ventilation systems.
GDET CEO , Anil Idnani, commented, “My team and company vision has always supported the longevity and worldwide integration of cryptocurrency. Not only have we seen a bullish spike in the market cap of cryptocurrency and strong support levels but also major announcements from companies like Facebook with the creation of their own currency, Libra. I am looking forward to work with Forest Hill Electric’s team once again to expand our facility and increase our Bitcoin hashrate.”
Management has already prepared the ASIC miners for immediate installation on site and is looking to upgrade the entire ventilation system with the purchase of additional, industrial-grade fans. Following the upgrade of the facility’s electric capacity, Forest Hill Electric was able to consult the Company on how to safely maximize the number of miners available for installation. At present, the Company is working to achieve the following near-term objectives:
Installation of brand new ASIC Bitcoin Miners
Installation of industrial-grade fans
Integrate the miners to increase overall hashrate
Engage third-party electricity providers to lower monthly power costs
Forest Hill Electric CEO Mike Fiore added, “My team is looking forward to upgrading this facility so that it can run at maximum capacity in a safe and controlled environment. We are also happy to announce that our company is officially working in house at the GDET mining facility, which will allow us to provide special attention to this project moving forward.”
GDET shareholders can expect new updates very soon as the Company continues to execute an aggressive phase of operational development and expansion.
Market Outlook:
Despite bitcoin pulling back after a colossal run in 2017, bitcoin enthusiasts still believe the cryptocurrency will be able to hit new highs consistently during the 2nd half of this year.
The $275 billion cryptocurrency market is continuing to experience a serious rally with bitcoin jumping over $13,000 once again.
Bitcoin , as well as blockchain (a transaction ledger that maintains identical copies across each member computer within a network), is being forecast as the Next Big Thing for the future.
For an idea of just how big blockchain may become, David Marcus, a vice president at Facebook , recently said he was stepping down from the board of directors at cryptocurrency exchange Coinbase. Instead he will be leading Facebook’s blockchain strategy. When you have the biggest social media company jumping on the blockchain bandwagon, it speaks in volumes of what hopes big companies have for this arena.
In 2017, the aggregate value of digital currencies, including bitcoin and ethereum , saw a jump of almost $600 billion, which in percentage terms was more than 3,300%. That’s a gain of 3,300% in only twelve months.
The share prices of semiconductor stocks such as NVIDIA , Advanced Micro Devices , and Taiwan Semiconductor Manufacturing Company, saw positive impacts in the last year as a result of seeing a strong demand from high performance computing like cryptocurrency mining.
(A report published by TrustNodes has revealed that Ethereum miners make almost $2.5 Billion on an annual basis!)
Famous Venture Capitalist Tim Draper once said that he thinks bitcoin will hit over $100,000. This is the man who said that Bitcoin will hit $10,000 in three years back in 2014. It hit almost $20,000 in 2017.
Draper has also responded to people questioning whether or not he will sell his bitcoin with this question: "Why would I sell the future for the past?"
Technical Analysis
As we mentioned above, GDET has a history of seeing rapid gains in the short term. Just last month, it hit over a penny when it was as low as $0.0055 at the end of April. The gain here was 100% in just a few days.
Earlier this year shares shares were as low as $0.0027 at the end of February and then hit $0.0229 in March for a Gain of Nearly 750% in Just a Few Weeks!
A move to $0.01 would show traders gains of up to +44.93%.
A move to $0.02 would show traders gains of up to +189.86%.
A move all the way to Goldman Small Cap Research's $0.06 target price would show traders gains of +782%!
The Bottom-Line
We love these subpenny alerts because even the smallest move can result in massive gains for traders.
Based on its past history, and our research, we believe that GDET could be our next subpenny alert to run-up for triple-digit gains.
Add it to the top of your watchlist immediately.
(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned here within, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated thirty five thousand dollars by ACN LLC to conduct a one day investor relations advertising and marketing campaign for GDET and 3000 Tradingview views. We have been previously compensated fifteen thousand dollars by ACN LLC to conduct a one-day investor relations advertising and marketing campaign for GDET on two seperate occasions-which have expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
Sentiment extremely Bearish, CME gap magnetic.
Crucial 12 hours for BTC and the entire crypto market as sentiment has turned extremely bearish and and Crypto Domesday dominates twitter again. If current supports fail sub $1000 very likely and a dreaded H&S in play.
Current supports
.5 FIb
200 EMA
Uptrend
Sentiment extremely Bearish, CME gap magnetic.
Crucial 12 hours for BTC and the entire crypto market as sentiment has turned extremely bearish and and Crypto Domesday dominates twitter again. If current supports fail sub $1000 very likely and a dreaded H&S in play.
Current supports
.5 FIb
200 EMA
Uptrend
MYND ANALYTICS STOCK PRICE COULD DOUBLE
INVESTORS ARE REWARDED FOR LOYALTY WITH MAJOR STOCK MOVES ON MERGER CLARITY
Yutaka Niihara, MD , MPH, CEO and Chairman of Emmaus, stated, "We are very grateful for this opportunity to merge with MYnd Analytics . The anticipated listing on Nasdaq via the merger with MYnd Analytics is an important step to maximize value for shareholders. We look forward to sharing with the public markets our progress on the market acceptance of Endari, which is indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years and older. Endari addresses a $3 billion global market. In addition to the treatment of sickle cell disease, we believe our platform technology has the potential to address other major clinical indications such as diverticulosis."
Robin Smith, Chairman of MYnd Analytics , commented, "We are pleased with the progress of the merger and spin-off transaction, which remains on track to close before the end of this month, subject to approval of shareholders. We believe this transaction will drive significant value for all shareholders, and we will provide further updates following the respective shareholder meetings."
AVERAGE ANALYSTS PRICE TARGET $4
AVERAGE ANALYSTS RECOMMENDATION BUY
COMPANY PROFILE
MYnd Analytics , Inc. operates as a predictive analytics company that has developed a decision support tool to help physicians reduce trial and error treatment in mental health and provide more personalized care to patients. It provides objective clinical decision support to mental healthcare providers for the personalized treatment of behavioural disorders, includes depression, anxiety, bipolar disorder, post-traumatic stress disorder, and other non-psychotic disorders. The company was founded by Leonard J. Brandt and Brain McDonald on March 20, 1987 and is headquartered in Aliso Viejo, CA.
MYND ANALYTICS STOCK PRICE COULD DOUBLE
INVESTORS ARE REWARDED FOR LOYALTY WITH MAJOR STOCK MOVES ON MERGER CLARITY
Yutaka Niihara, MD , MPH, CEO and Chairman of Emmaus, stated, "We are very grateful for this opportunity to merge with MYnd Analytics . The anticipated listing on Nasdaq via the merger with MYnd Analytics is an important step to maximize value for shareholders. We look forward to sharing with the public markets our progress on the market acceptance of Endari, which is indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years and older. Endari addresses a $3 billion global market. In addition to the treatment of sickle cell disease, we believe our platform technology has the potential to address other major clinical indications such as diverticulosis."
Robin Smith, Chairman of MYnd Analytics , commented, "We are pleased with the progress of the merger and spin-off transaction, which remains on track to close before the end of this month, subject to approval of shareholders. We believe this transaction will drive significant value for all shareholders, and we will provide further updates following the respective shareholder meetings."
AVERAGE ANALYSTS PRICE TARGET $4
AVERAGE ANALYSTS RECOMMENDATION BUY
COMPANY PROFILE
MYnd Analytics , Inc. operates as a predictive analytics company that has developed a decision support tool to help physicians reduce trial and error treatment in mental health and provide more personalized care to patients. It provides objective clinical decision support to mental healthcare providers for the personalized treatment of behavioural disorders, includes depression, anxiety, bipolar disorder, post-traumatic stress disorder, and other non-psychotic disorders. The company was founded by Leonard J. Brandt and Brain McDonald on March 20, 1987 and is headquartered in Aliso Viejo, CA.
YUMA SETTING UP FOR MAJOR BREAKOUT
THIS IS PURELY A SPECULATIVE AND RUMOUR BASED ANALYSIS ON UNUSUAL ACTIVITY ON VOLUME AND PRICE SPIKE.
COMPANY PROFILE
Yuma Energy, Inc. operates as an independent exploration and production company. It focuses on the acquisition, development and exploration for conventional and unconventional oil and natural gas resources, primarily in the U.S. Gulf Coast, the Permian Basin of west Texas and California. The firm have non-operated positions in the East Texas Eagle Ford and Woodbine and the Bakken Shale in North Dakota, and operated positions in Kern and Santa Barbara Counties in California. The company was founded by Sam L. Banks on September 10, 2014 and is headquartered in Houston, TX .
YUMA SETTING UP FOR MAJOR BREAKOUT
THIS IS PURELY A SPECULATIVE AND RUMOUR BASED ANALYSIS ON UNUSUAL ACTIVITY ON VOLUME AND PRICE SPIKE.
COMPANY PROFILE
Yuma Energy, Inc. operates as an independent exploration and production company. It focuses on the acquisition, development and exploration for conventional and unconventional oil and natural gas resources, primarily in the U.S. Gulf Coast, the Permian Basin of west Texas and California. The firm have non-operated positions in the East Texas Eagle Ford and Woodbine and the Bakken Shale in North Dakota, and operated positions in Kern and Santa Barbara Counties in California. The company was founded by Sam L. Banks on September 10, 2014 and is headquartered in Houston, TX .
ANFI has bottomed out and is ready to bounce hard.
=====================
ANFI ( Amira Nature Foods Ltd .)
Float: 25.82M
Alert Price: $0.7034
Target Price: $6.00
Chart Analysis
Investor Presentation
Investor Webcast
Website | Recent News
========================
Members,
We are following up today's +15% winner with an NYSE listed company that could see its share price more than double in the immediate future.
We ask that you immediately add ANFI ( Amira Nature Foods Ltd .) to the top of your watchlist.
This ticker has provided our members with several opportunities to profit each and everytime we have brought it to your attention.
June 20th: +8.54% Gain!
June 17th: +17% Gain!
March 14th: +62.28% Gain! (Multi-Day)
And let's not forget about ANFI's epic bull run earlier this year, in which members secured up to +320% in long-term profits as it ran from $0.44 to $1.85!
There are obviously no guarantees on Wall St ., but ANFI has been as close to a sure a thing as we have ever seen.
This is by far the most attractive entry point that we have ever alerted ANFI at,
ANFI is currently trading near the lower end of its 52-week price channel , but in our opinion that just means its upside potential far outweighs any downside risk!
We've done our very own chart analysis and we believe that a bullish reversal is just beginning to shape up.
In fact we see the potential for a move of over +77%!
Especially since the Company has recently made some market friendly announcements that we believe will serve as huge catalysts for a bullish uptrend
Signed a new contract to supply rice to a customer in the Europe, Middle East, and Africa (“EMEA”) region in the amount of $6 million. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020.
This along with their previously announced customer orders, amounts to over $57mn in revenue. This equates to securing 29% of our forecasted $200mn of FY2020 revenue just 63 days (17%) into the fiscal year”, stated Karan A. Chanana, Amira’s Chairman.
Announced the hiring of Brian M. Speck as Chief Financial Officer. With his many years of U.S. public company accounting experience Mr. Speck will assist ANFI in Westernizing their finance department as they focus on the international growth of their brands.
Entered into contracts, which consist of approximately $9 million in revenue, to supply rice and institutional products to new customers in the Europe, Middle East, and Africa (“EMEA”) and Asia regions.
ANFI's recent strategic moves have us extremely bullish on this past triple-digit winner.
But we're not the only ones...
Top 10 Wealth Firm Puts $6.00 Price Target on a $0.70 Stock
Jefferies analyst Akshay Jagdale recently maintained his Buy rating on ANFI and set a price target of $6.
That's an upside of +757% from today's alert price!
If you go to Google and search for the "Top 10 Wealth Firms" you'll notice that " Jefferies Wealth Management" is in the top 10 in the country.
If that wasn't enough to have you sold on ANFI , you'll be happy to know that Jefferies isn't the only equity research firm that is bullish on ANFI ...
Diamond Equity Research, a leading equity research and corporate access firm with a focus on small capitalization public companies recently initiated coverage on ANFI , and slapped on a $4.00 price target!
That's well over +471% in upside potential from today's alert price.
Their full research report is available here.
To say that ANFI is undervalued at its current share price would be the understatement of the year.
Here are a few other catalysts that coud have ANFI trading back over $1.00 in no time:
Low float of just 25.82M
Listed on the NYSE (High Liquidity)
Products now available on Amazon in the United Kingdom. The Company is initially offering its Brown Basmati Rice 2kg product and is looking forward to adding more products.
Reiterated its $200 million revenue guidance for the 2020 fiscal year ending March 31, 2020. Going forward, the Company’s focus will be on strengthening its international business and as such the 2020 fiscal year $200 million revenue guidance consists solely of international revenue (ex-India).
Jefferies analyst Akshay Jagdale recently maintained his Buy rating on ANFI and set a price target of $6.
Trading well below its average analyst price target of $6.00 (+630% Upside)
Its previously announced $30 million contract to supply third party branded basmati rice to a repeat customer in the Europe, Middle East, and Africa (“EMEA”) region was increased to $42 million within the provisions of the contract. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020.
It's Indian subsidiary, Amira Foods India (“Amira India”), has converted Amira India debt into ordinary shares of Amira India. As a result of the debt conversion, the Company’s ownership in Amira India decreased from 80.4% to 49.8%. This event is a continuation of Amira’s focus on strengthening the Company’s international business.
It is our opinion that ANFI is shaping up to be one of the top growth/value plays listed on the NYSE at the moment.
As such, we ask that all members start their research on ANFI immediately, and consider building a position tomorrow morning at 9:30AM EST
About Amira Nature Foods
Founded in 1915, Amira has evolved into a global provider of packaged Indian specialty rice, with sales in over 40 countries today. Amira sells Basmati rice, premium long-grain rice grown only in certain regions of the Indian sub-continent, under their flagship Amira brand as well as under other third party brands. Amira sells its products primarily in emerging markets through a broad distribution network. Amira’s headquarters are in Dubai, United Arab Emirates, and it also has offices in India, Germany, the United Kingdom, and the United States.
Company Highlights:
Large Staple Consumer Category with Highly Supportive Industry and Sub Category Fundamentals
A Market Lead with Differentiated Business Model
Globally Diversified with Wide Customer Base and Broad Product Portfolio
Vertically Integrated "State-of-the-art" Supply Chain and Operations
Strong Financial Track Record, Underpinned by Stable Margins
Highly Experienced and Successful Management Team
Announced that its previously announced $30 million contract to supply third party branded basmati rice to a repeat customer in the Europe, Middle East, and Africa (“EMEA”) region was increased to $42 million within the provisions of the contract. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020.
Since its founding in 1915, Amira has evolved from a domestic, family owned Indian business to a professionally managed, global branded, publicly traded, growing packaged food company.
Not only is the stock potentially undervalued based on its revenues and earnings , ANFI is also trading well below its book value, with a price-to-book ratio of 0.10, while the industry average is 1.81.
With ANFI trading well below the industry average for some key valuation ratios, it could be a value play, and could even attract potential buyers.
Moreover, Amira was able to increase at a compound annual growth rate of 15.5% between 2010 and 2017. With such high revenue growth rates, this company could be significantly undervalued by the market.
According to Finviz, over 50% of the company is owned by insiders. That in mind, that shows that the company’s officers, directors, and key insiders are confident in the company.
The Company has received numerous accolades:
Since 2010, Amira has been recognized in multiple years by the World Economic Forum as a “Global Growth Company”, an
invitation-only community consisting of ~300 of the world’s fastest-growing corporations
The World Consulting & Research Corporation named Amira one of “Asia’s Most Promising Brands”
Planman Marcom voted Amira the “INDIAN POWERBRAND” in the Food Category in 2011 and 2013
Amir was voted best partner in the “Staples” category in 2013 at the Bharti Walmart Private Limited Annual Supplier Conference
VWP World Brand recognized the Amira Brand as “The Admired Brand of India” in 2014–2015
Inc. India featured Amira as one of India’s fastest growing mid-sized companies in 2010, 2011, 2012 and 2013
Product Portfolio
Approximately three quarters of sales come from Basmati rice, the core focus of the company;
Sells more than 20 owned brands globally, spanning numerous price points;
Amira in India
Amira has established 15 Company managed distribution centers in India to provide it greater control over its expansion efforts in its home country location.
Amira is one of a handful of large relevant players in the domestic India market.
Amira represents a meaningful opportunity to consolidate the market over time.
Business Is Growing, Strategic Moves Will Expedite Growth
Amira Foods is no startup. The international business is healthy and generated roughly $270 million in sales in 2018. Those numbers are coupled with respectable margins that rested at 14.3% of gross sales. However, the company expects to do better with the expectation to add an additional 100bp to the international margins. Notably, there will some be shrinkage to the margins, which may be adjusted lower to account for the separation of the Indian business, due to less vertical integration and less sourcing from the primary processor. However, even with the expected reductions in the margin and certain efficiencies, analysts are pointing to ANFI being able to maintain separate sales of roughly $200 million, albeit with a lower margin of approximately 650bp. However, even with the expected short-term declines, the assumption of the lesser $200 million in sales coupled with an EBITDA margin of an expected 8.8%, can imply that ANFI will generate a positive EBITDA run of roughly $17 million. And, that is a healthy number to build upon.
Source: https://seekingalpha.com/instablog/49294...
Recent Developments
Appointment of Thomas Dennhardt (formerly Lidl) to CEO of Amira Basmati Rice GmbH (German subsidiary)
Board appointment of Hervé Larren (formerly LVMH), bringing experience in building brands internationally
EUR25mn Debt raise at 8.5% interest rate (due December 2023)
Reduced ownership of India subsidiary to 49.8%
Regains Compliance with NYSE Listing Requirements
Amira Nature Foods Ltd Announces New Contract of $6 Million
Earlier this month ANFI announced a new contract to supply rice to a customer in the Europe, Middle East, and Africa (“EMEA”) region in the amount of $6 million. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020.
“We are extremely pleased to announce this development, which along with our previously announced customer orders, amounts to over $57mn in revenue. This equates to securing 29% of our forecasted $200mn of FY2020 revenue just 63 days (17%) into the fiscal year”, stated Karan A. Chanana, Amira’s Chairman.
Further information on the Company, including an updated investor presentation and other information, can be found on the Company’s website at http://www.amira.net.
Market Outlook:
Amira operates in the global packaged rice market and is a leading provider of Basmati rice, a long-grain aromatic rice with favorable health attributes that can be grown only in specific regions of the Indian sub-continent and part of the Punjab region located in Pakistan. The global rice market is an enormous market with stable growth, while specialty rice and specifically Basmati rice benefits from premium pricing and increasing consumption patterns. Demand for Basmati rice has remained strong over the past 10 years due to the increased consumption trends both in India and internationally. Leading players such as McCormick & Co., Hain Celestial, Rice 'n Spice, LT Foods , East End Foods , and Amira Nature Foods serve local as well as global consumers, which is reflected in the growth of Basmati rice market. The size of worldwide Basmati rice market was approximately $10.51 Billion in 2017 and is estimated to be worth $17.74 Billion by the end of 2022, with a robust CAGR of 11% between 2017 and 2022, according to Transparency Market Research (TMR).
Rice is a $275bn Global Staple Category with Favorable Market Conditions
Rice is the primary staple for >50% of the world’s population and provides > 20% of the global caloric intake
Represents 30% of caloric consumption in Asia(4)
Defensive and non-cyclical with steady growth
Improves with age and has an extremely long shelf life (up to 5+ years) if stored properly
Global rice consumption is growing, estimated to reach c.483 million metric tonnes in 2017(5)
The global rice market is estimated at $275B and has grown at 2% volume CAGR over the 2010 – 2015 period
Technical Analysis
As we stated above, we've done our very own chart analysis and see the potential for a move of over +77% from here!
We see a positive reversal from long-term support right here, and a positive cross looks imminent.
The float of ANFI is extremely low for a NYSE listed company at just 25.82M.
We know this ticker can make big moves on volume , so we wouldn't be too surprised if this ticker starts to breakout early.
With its bullish $6.00 price target, we believe its upside potential far outweighs any downside risk.
The Bottom Line
ANFI has proven its ability run-up big in both the short and long-term.
ANFI has the potential to be the biggest gainer on the NYSE, and deserves to be on the top of your watchlist.
That being said, we ask that all members start their research on ANFI immediately, and consider building a position tomorrow morning at 9:30AM EST
(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned here within, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated fifteen thousand dollars by World Wide Holdings dba Invictus Resources for a 1-day investor relations advertising marketing campaign w/ 1000 TradingView™ views for ANFI . We have previously been compensated ten thousand dollars by World Wide Holdings dba Invictus Resources In LLC to conduct investor relations advertising and marketing for ANFI on five separate occasions which have expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
ANFI has bottomed out and is ready to bounce hard.
=====================
ANFI ( Amira Nature Foods Ltd .)
Float: 25.82M
Alert Price: $0.7034
Target Price: $6.00
Chart Analysis
Investor Presentation
Investor Webcast
Website | Recent News
========================
Members,
We are following up today's +15% winner with an NYSE listed company that could see its share price more than double in the immediate future.
We ask that you immediately add ANFI ( Amira Nature Foods Ltd .) to the top of your watchlist.
This ticker has provided our members with several opportunities to profit each and everytime we have brought it to your attention.
June 20th: +8.54% Gain!
June 17th: +17% Gain!
March 14th: +62.28% Gain! (Multi-Day)
And let's not forget about ANFI's epic bull run earlier this year, in which members secured up to +320% in long-term profits as it ran from $0.44 to $1.85!
There are obviously no guarantees on Wall St ., but ANFI has been as close to a sure a thing as we have ever seen.
This is by far the most attractive entry point that we have ever alerted ANFI at,
ANFI is currently trading near the lower end of its 52-week price channel , but in our opinion that just means its upside potential far outweighs any downside risk!
We've done our very own chart analysis and we believe that a bullish reversal is just beginning to shape up.
In fact we see the potential for a move of over +77%!
Especially since the Company has recently made some market friendly announcements that we believe will serve as huge catalysts for a bullish uptrend
Signed a new contract to supply rice to a customer in the Europe, Middle East, and Africa (“EMEA”) region in the amount of $6 million. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020.
This along with their previously announced customer orders, amounts to over $57mn in revenue. This equates to securing 29% of our forecasted $200mn of FY2020 revenue just 63 days (17%) into the fiscal year”, stated Karan A. Chanana, Amira’s Chairman.
Announced the hiring of Brian M. Speck as Chief Financial Officer. With his many years of U.S. public company accounting experience Mr. Speck will assist ANFI in Westernizing their finance department as they focus on the international growth of their brands.
Entered into contracts, which consist of approximately $9 million in revenue, to supply rice and institutional products to new customers in the Europe, Middle East, and Africa (“EMEA”) and Asia regions.
ANFI's recent strategic moves have us extremely bullish on this past triple-digit winner.
But we're not the only ones...
Top 10 Wealth Firm Puts $6.00 Price Target on a $0.70 Stock
Jefferies analyst Akshay Jagdale recently maintained his Buy rating on ANFI and set a price target of $6.
That's an upside of +757% from today's alert price!
If you go to Google and search for the "Top 10 Wealth Firms" you'll notice that " Jefferies Wealth Management" is in the top 10 in the country.
If that wasn't enough to have you sold on ANFI , you'll be happy to know that Jefferies isn't the only equity research firm that is bullish on ANFI ...
Diamond Equity Research, a leading equity research and corporate access firm with a focus on small capitalization public companies recently initiated coverage on ANFI , and slapped on a $4.00 price target!
That's well over +471% in upside potential from today's alert price.
Their full research report is available here.
To say that ANFI is undervalued at its current share price would be the understatement of the year.
Here are a few other catalysts that coud have ANFI trading back over $1.00 in no time:
Low float of just 25.82M
Listed on the NYSE (High Liquidity)
Products now available on Amazon in the United Kingdom. The Company is initially offering its Brown Basmati Rice 2kg product and is looking forward to adding more products.
Reiterated its $200 million revenue guidance for the 2020 fiscal year ending March 31, 2020. Going forward, the Company’s focus will be on strengthening its international business and as such the 2020 fiscal year $200 million revenue guidance consists solely of international revenue (ex-India).
Jefferies analyst Akshay Jagdale recently maintained his Buy rating on ANFI and set a price target of $6.
Trading well below its average analyst price target of $6.00 (+630% Upside)
Its previously announced $30 million contract to supply third party branded basmati rice to a repeat customer in the Europe, Middle East, and Africa (“EMEA”) region was increased to $42 million within the provisions of the contract. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020.
It's Indian subsidiary, Amira Foods India (“Amira India”), has converted Amira India debt into ordinary shares of Amira India. As a result of the debt conversion, the Company’s ownership in Amira India decreased from 80.4% to 49.8%. This event is a continuation of Amira’s focus on strengthening the Company’s international business.
It is our opinion that ANFI is shaping up to be one of the top growth/value plays listed on the NYSE at the moment.
As such, we ask that all members start their research on ANFI immediately, and consider building a position tomorrow morning at 9:30AM EST
About Amira Nature Foods
Founded in 1915, Amira has evolved into a global provider of packaged Indian specialty rice, with sales in over 40 countries today. Amira sells Basmati rice, premium long-grain rice grown only in certain regions of the Indian sub-continent, under their flagship Amira brand as well as under other third party brands. Amira sells its products primarily in emerging markets through a broad distribution network. Amira’s headquarters are in Dubai, United Arab Emirates, and it also has offices in India, Germany, the United Kingdom, and the United States.
Company Highlights:
Large Staple Consumer Category with Highly Supportive Industry and Sub Category Fundamentals
A Market Lead with Differentiated Business Model
Globally Diversified with Wide Customer Base and Broad Product Portfolio
Vertically Integrated "State-of-the-art" Supply Chain and Operations
Strong Financial Track Record, Underpinned by Stable Margins
Highly Experienced and Successful Management Team
Announced that its previously announced $30 million contract to supply third party branded basmati rice to a repeat customer in the Europe, Middle East, and Africa (“EMEA”) region was increased to $42 million within the provisions of the contract. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020.
Since its founding in 1915, Amira has evolved from a domestic, family owned Indian business to a professionally managed, global branded, publicly traded, growing packaged food company.
Not only is the stock potentially undervalued based on its revenues and earnings , ANFI is also trading well below its book value, with a price-to-book ratio of 0.10, while the industry average is 1.81.
With ANFI trading well below the industry average for some key valuation ratios, it could be a value play, and could even attract potential buyers.
Moreover, Amira was able to increase at a compound annual growth rate of 15.5% between 2010 and 2017. With such high revenue growth rates, this company could be significantly undervalued by the market.
According to Finviz, over 50% of the company is owned by insiders. That in mind, that shows that the company’s officers, directors, and key insiders are confident in the company.
The Company has received numerous accolades:
Since 2010, Amira has been recognized in multiple years by the World Economic Forum as a “Global Growth Company”, an
invitation-only community consisting of ~300 of the world’s fastest-growing corporations
The World Consulting & Research Corporation named Amira one of “Asia’s Most Promising Brands”
Planman Marcom voted Amira the “INDIAN POWERBRAND” in the Food Category in 2011 and 2013
Amir was voted best partner in the “Staples” category in 2013 at the Bharti Walmart Private Limited Annual Supplier Conference
VWP World Brand recognized the Amira Brand as “The Admired Brand of India” in 2014–2015
Inc. India featured Amira as one of India’s fastest growing mid-sized companies in 2010, 2011, 2012 and 2013
Product Portfolio
Approximately three quarters of sales come from Basmati rice, the core focus of the company;
Sells more than 20 owned brands globally, spanning numerous price points;
Amira in India
Amira has established 15 Company managed distribution centers in India to provide it greater control over its expansion efforts in its home country location.
Amira is one of a handful of large relevant players in the domestic India market.
Amira represents a meaningful opportunity to consolidate the market over time.
Business Is Growing, Strategic Moves Will Expedite Growth
Amira Foods is no startup. The international business is healthy and generated roughly $270 million in sales in 2018. Those numbers are coupled with respectable margins that rested at 14.3% of gross sales. However, the company expects to do better with the expectation to add an additional 100bp to the international margins. Notably, there will some be shrinkage to the margins, which may be adjusted lower to account for the separation of the Indian business, due to less vertical integration and less sourcing from the primary processor. However, even with the expected reductions in the margin and certain efficiencies, analysts are pointing to ANFI being able to maintain separate sales of roughly $200 million, albeit with a lower margin of approximately 650bp. However, even with the expected short-term declines, the assumption of the lesser $200 million in sales coupled with an EBITDA margin of an expected 8.8%, can imply that ANFI will generate a positive EBITDA run of roughly $17 million. And, that is a healthy number to build upon.
Source: https://seekingalpha.com/instablog/49294...
Recent Developments
Appointment of Thomas Dennhardt (formerly Lidl) to CEO of Amira Basmati Rice GmbH (German subsidiary)
Board appointment of Hervé Larren (formerly LVMH), bringing experience in building brands internationally
EUR25mn Debt raise at 8.5% interest rate (due December 2023)
Reduced ownership of India subsidiary to 49.8%
Regains Compliance with NYSE Listing Requirements
Amira Nature Foods Ltd Announces New Contract of $6 Million
Earlier this month ANFI announced a new contract to supply rice to a customer in the Europe, Middle East, and Africa (“EMEA”) region in the amount of $6 million. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020.
“We are extremely pleased to announce this development, which along with our previously announced customer orders, amounts to over $57mn in revenue. This equates to securing 29% of our forecasted $200mn of FY2020 revenue just 63 days (17%) into the fiscal year”, stated Karan A. Chanana, Amira’s Chairman.
Further information on the Company, including an updated investor presentation and other information, can be found on the Company’s website at http://www.amira.net.
Market Outlook:
Amira operates in the global packaged rice market and is a leading provider of Basmati rice, a long-grain aromatic rice with favorable health attributes that can be grown only in specific regions of the Indian sub-continent and part of the Punjab region located in Pakistan. The global rice market is an enormous market with stable growth, while specialty rice and specifically Basmati rice benefits from premium pricing and increasing consumption patterns. Demand for Basmati rice has remained strong over the past 10 years due to the increased consumption trends both in India and internationally. Leading players such as McCormick & Co., Hain Celestial, Rice 'n Spice, LT Foods , East End Foods , and Amira Nature Foods serve local as well as global consumers, which is reflected in the growth of Basmati rice market. The size of worldwide Basmati rice market was approximately $10.51 Billion in 2017 and is estimated to be worth $17.74 Billion by the end of 2022, with a robust CAGR of 11% between 2017 and 2022, according to Transparency Market Research (TMR).
Rice is a $275bn Global Staple Category with Favorable Market Conditions
Rice is the primary staple for >50% of the world’s population and provides > 20% of the global caloric intake
Represents 30% of caloric consumption in Asia(4)
Defensive and non-cyclical with steady growth
Improves with age and has an extremely long shelf life (up to 5+ years) if stored properly
Global rice consumption is growing, estimated to reach c.483 million metric tonnes in 2017(5)
The global rice market is estimated at $275B and has grown at 2% volume CAGR over the 2010 – 2015 period
Technical Analysis
As we stated above, we've done our very own chart analysis and see the potential for a move of over +77% from here!
We see a positive reversal from long-term support right here, and a positive cross looks imminent.
The float of ANFI is extremely low for a NYSE listed company at just 25.82M.
We know this ticker can make big moves on volume , so we wouldn't be too surprised if this ticker starts to breakout early.
With its bullish $6.00 price target, we believe its upside potential far outweighs any downside risk.
The Bottom Line
ANFI has proven its ability run-up big in both the short and long-term.
ANFI has the potential to be the biggest gainer on the NYSE, and deserves to be on the top of your watchlist.
That being said, we ask that all members start their research on ANFI immediately, and consider building a position tomorrow morning at 9:30AM EST
(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned here within, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated fifteen thousand dollars by World Wide Holdings dba Invictus Resources for a 1-day investor relations advertising marketing campaign w/ 1000 TradingView™ views for ANFI . We have previously been compensated ten thousand dollars by World Wide Holdings dba Invictus Resources In LLC to conduct investor relations advertising and marketing for ANFI on five separate occasions which have expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
$30 Million buyback announced by American Eagle Outfitters
American Eagle Outfitters announces that the board authorized an additional 30M shares for repurchase through February 3, 2024.
The retailer says the new buyback allowance brings the shares available for purchase under the company's publicly announced share repurchase authorizations to approximately 37.4M shares.
"Consistent financial performance has led to strong free cash flow and a substantial cash balance even after making investments in our business to fuel future growth. The increased authorization and continuation of our cash dividend policy underscore our confidence in long-term growth initiatives and AEO’s commitment to delivering shareholder returns," notes AEO Jay Schottenstein.
By: Clark Schultz, SA News Editor
$30 Million buyback announced by American Eagle Outfitters
American Eagle Outfitters announces that the board authorized an additional 30M shares for repurchase through February 3, 2024.
The retailer says the new buyback allowance brings the shares available for purchase under the company's publicly announced share repurchase authorizations to approximately 37.4M shares.
"Consistent financial performance has led to strong free cash flow and a substantial cash balance even after making investments in our business to fuel future growth. The increased authorization and continuation of our cash dividend policy underscore our confidence in long-term growth initiatives and AEO’s commitment to delivering shareholder returns," notes AEO Jay Schottenstein.
By: Clark Schultz, SA News Editor
MC EWEN MINING announce positive exploration results.
AFTERHOURS ANNOUNCEMENT
McEwen Mining drives a potential new source of production McEwen Mining is pleased to report positive exploration results from the 147NE Target, which was initially discovered in 2018.The Grey Fox Area is located 5 km south of the Black Fox Mine and is comprised of three deposits: 147, Contact and South, and two targets: 147NE and Gibson. The deposits cumulatively host an estimated Indicated resource of 465,000 ounces of gold . The Company is conducting a scoping study to evaluate the economics of mining these three deposits and two target areas via a central underground ramp system.
Read more at:
https://thefly.com/landingPageNews.php?i...
AVERAGE ANALYSTS PRICE TARGET $2.63
AVERAGE ANALYSTS RECOMMENDATION BUY
SHORT INTEREST 17.28%
COMPANY PROFILE
McEwen Mining, Inc. is a mining and minerals production and exploration company, which focuses on base metals in Argentina, Mexico and the United States. It operates through the following geographical segments: Mexico, MSC, Nevada, Los Azules, Canada and Other. The company was founded on July 24, 1979 and is headquartered in Toronto, Canada.
MC EWEN MINING announce positive exploration results.
AFTERHOURS ANNOUNCEMENT
McEwen Mining drives a potential new source of production McEwen Mining is pleased to report positive exploration results from the 147NE Target, which was initially discovered in 2018.The Grey Fox Area is located 5 km south of the Black Fox Mine and is comprised of three deposits: 147, Contact and South, and two targets: 147NE and Gibson. The deposits cumulatively host an estimated Indicated resource of 465,000 ounces of gold . The Company is conducting a scoping study to evaluate the economics of mining these three deposits and two target areas via a central underground ramp system.
Read more at:
https://thefly.com/landingPageNews.php?i...
AVERAGE ANALYSTS PRICE TARGET $2.63
AVERAGE ANALYSTS RECOMMENDATION BUY
SHORT INTEREST 17.28%
COMPANY PROFILE
McEwen Mining, Inc. is a mining and minerals production and exploration company, which focuses on base metals in Argentina, Mexico and the United States. It operates through the following geographical segments: Mexico, MSC, Nevada, Los Azules, Canada and Other. The company was founded on July 24, 1979 and is headquartered in Toronto, Canada.
RLLVF to rally on Exclusivity Agreement with SOS Cannabis Inc
=====================
RLLVF (Relevium Technologies Inc.)
Current Price: $0.0592
Float: 122.64M
Website | Recent News
========================
Legal Cannabis is Expected to Grow 230%, to $31.3 Billion in 2022
Global spending on legal cannabis is expected to grow 230%, to $31.3 billion in 2022, compared to $9.5 billion in 2017, according to Arcview Market Research and BDS Analytics. The research suggests that most of that, nearly $23.4 billion, will be spent in the U.S. With more states voting for the legalization of marijuana and business interest sparking, that definitely makes sense.
Marijuana Regulation: The Facts
While Canada legalized marijuana in late 2018, it remains illegal under federal U.S. law and is still classified as a controlled substance without proven medical benefit, along with heroin and LSD. However, with some 30 states voting to make cannabis legal for medicinal use, recreational use, or both, marijuana regulation in the U.S. essentially is a hot mess.
30 states have approved the legalization of marijuana for medical or recreational use or both.
In 2018 alone, the following states voted in favor of marijuana legalization:
Michigan: Voters legalized marijuana use and cultivation for people over the age of 21 and authorized the commercial sale of marijuana through state-licensed retailers.
Missouri: Voters approved legalizing marijuana for medical purposes and allowing patients to cultivate plants at home.
Oklahoma: Voters approved legalizing marijuana for medical use.
Utah: Voters approved some use of marijuana for medical purposes.
Who are the Top Players in this Sector at the Moment
Canopy Growth Corp. ( CGC )
The first Canadian marijuana company, Canopy Growth Corp. is the world's largest publicly-traded weed company. The company owns and operates many brands, producing and marketing both medical and recreational strains. Tweed is one of the company's most popular brands, thanks to an association with rapper Snoop Dogg. For its 2019 fiscal year, it reported revenue of CAD 77.9 million or nearly $60 million.
In October 2017, Constellation Brands , the beverage giant, and maker of Corona beer bought a 9.9% stake in Canopy Growth. The deal offers both companies a chance at new product lines such as cannabis-infused beverages.
Aurora Cannabis Inc. ( ACB )
Another big Canadian pot company, Aurora Cannabis became even bigger in March by acquiring rival MedReleaf in a $250 million all-stock deal that was touted as the world's largest marijuana deal to date. Consolidating operations will help the new entity cut costs and gain efficiency. According to a press release, Aurora and MedReleaf together expect to produce over 570,000 kilograms per year of cannabis through nine facilities in Canada and two in Denmark.
Aurora debuted on the Canadian venture stock exchange (TSX) in October 2016 and trades in the U.S. on the NYSE.
Cronos Group Inc . ( CRON )
Nasdaq's first pot stock, Cronos Group is a Toronto-based cultivator of medical marijuana . In addition to Canada, Cronos serves international markets, shipping its products to Germany, building a facility in Israel, and starting a joint venture in Australia. Cronos Group does not have a presence in the U.S. due to the uncertainty in regulations.
As of its 2018 fiscal year, the company generated $7.3 million in revenue.
The Top Players Offer Little Upside Potential
Over the last 12 months, there has been tremendous hype on cannabis stocks. The widespread legalization in some states in the U.S. and all of Canada caused many stocks related to the pot industry to skyrocket, leaving little upside potential for investors late to the party.
However, there are still some juicy opportunities out there...
We've Found A Cannabis Stock That Still Has Plenty Of Room To Run
That company is Relevium Technologies, and it is publicly traded in three countries on three separate exchanges OTCQB: “RLLVF”, TSX.V: “RLV”, and Frankfurt: “6BX”.
Relevium Technologies is hitting on all cylinders from both a business and technical perspective, and they recently released some market friendly news that is sure to grab the attention of Wall Street.
The Company signed an exclusivity agreement to partner with SOS cannabis Inc. (“SOSCannabis”), which will provide pediatric customers with the ability to obtain free legal representation to seek reimbursement for the costs of medical cannabinoid therapy from different government agencies for the treatment of medical conditions for pediatric patients.
The partnership agreement will provide Relevium’s pediatric customers with access to an experienced legal and case management team, who will prepare the case file and seek retroactive and prospective reimbursement for parents of pediatric patients at no cost. The agreement provides Relevium with a unique advantage in terms of its business development strategy and first to market positioning in terms of pediatric applications.
Mr. Aurelio Useche, CEO of Relevium stated: “As we prepare to enter the pediatric endo-medicinal market in Canada with an initial ten (10) CannaKids® formulated products, not only are we providing parents with a natural alternative and/or health support mechanism, but now we are able to provide them with the ability to seek reimbursement from governmental agencies without any costs,” Mr. Useche stated further: “We are extremely happy to work with a team of caring legal professionals that can represent our customers in minimizing the financial burden of cannabinoid therapy.”
Maitre Robert Astell, President of SOSCannabis.com stated “We are delighted to welcome Relevium into our family of medicinal cannabinoid therapy suppliers. The focus and quest of Relevium in terms of pediatric patients is admirable and we look forward to onboarding parents into our fully-automated registration platform and to provide them with the state-of-the-art case management service in fulfilling their need for economic assistance in providing natural medicine to their children.”
Tracy Ryan, CEO of Cannakids® stated: “For years patients have struggled with the high expenses that come along with using cannabis as a medicine. Especially parents to sick children who often lose their jobs due to countless hospital stays and doctor’s appointments. This new opportunity for families is a major step in the right direction. We are elated that more will now have the opportunity to afford this powerful, non-toxic option that we have seen bring unimaginable relief to patients on a global scale.”
About Relevium Technologies
Relevium Technologies operates in the health and wellness industry, including legal cannabis, with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operations of brands and businesses in the health and wellness markets and medical cannabis. The Company pursues its business strategy through an acquisition and partnership model in a holistic approach to encompass a wide range of health and wellness consumer products.
Relevium’s products are part of the $3.72 trillion dollar global wellness industry — one of the fastest growing worldwide markets. Their specific focus is on products that promote overall health, nutraceuticals, fitness nutrition and cosmeceuticals. The company already has 25 products being sold on Amazon with more being planned.
Relevium operates through two wholly owned subsidiaries:
BGX E-Health LLC (BGX), based in Orlando, Florida, markets dietary supplements, nutraceuticals, sports nutrition and cosmeceuticals primarily through its Bioganix® brand portfolio in the US and Europe. Relevium’s premium brands are sold at some of the world’s largest retailers including such as Walmart.com and Amazon.com.
The company’s product offering includes cutting-edge line of weight-loss, anti-inflammatory, heart, vision, beauty and fitness supplements sold through their Bioganix®, Push & Pull System® and LeefyLyfe® brands with the objective of helping people lose weight, become healthier, happier, and most importantly achieve the results that our customers desire.
Bioganix®, founded in 2014, has some of the best-selling products in the Health and Personal Care category on Amazon, and a loyal customer base. The combination of online marketing with an emphasis on superior quality products backed by stringent scientific research and formulations, this has developed Bioganix® in becoming one of the leading dietary supplement brands online.
Push & Pull®, launched in 2019, is the first comprehensive natural anti-aging system for complete skin care that combines Collagen Protein supplements (PUSH) and naturally sourced Aloe Vera skin anti-aging cream (PULL). This new brand targets a brand-new revenue stream in the burgeoning cosmeceutical market, which is the fastest growing segment of the health and wellness Market.
LeefyLyfe® is their OTC cannabidiol Phyto formulated brand that combines the same trusted ingredients as those found in Bioganix® and Push & Pull® with the benefits of CBD . The company is currently waiting for the decision by the FDA to allow the sale of CBD as a supplement in order to release its products into the market.
Since 2017, Relevium’s OTC has grown its product offering and expanded its distribution channels to some of the largest online marketplaces such as eBay , Amazon and Walmart.com. Relevium will continue to innovate with the BioGanix brand, expand the product line and distribution channels to further drive growth.
Biocannabix Health Corporation (BCX), based in Montreal, Quebec, is a biopharma nutraceutical company focused on delivering pediatric endo-medicinal nutraceuticals for cannabinoid therapy.
The company combines leading biopharma expertise, agricultural and logistic advantages of Colombia and trusted brand status with a clinically validation process for Phyto therapeutic medical products aimed at pediatric applications.
Biocannabix’ vertically integrated operations are located in key markets around the world: Canada, Colombia and Germany.
Scientific and Administrative Offices located in Montreal, Quebec
Cultivation and Extraction operations with an initial 20 hectares located in Cali , Colombia
Distribution and compliance partnership in Germany
The portfolio of Biocannabix brands include:
Cannakids®: Pediatric brand exclusive for the Canadian market
Relevium Senior®: Geriatric brand targeting inflammatory conditions including joints, heart and brain.
Relevium Kids®: Pediatric brand of Nutraceuticals and Oral Nutritional Supplements
Investment Highlights:
In 2017, the global wellness market reached $4.2T.
Global nutraceutical market to reach US$578.23B by 2025.
Vast distribution network through industry giants like Walmart and Amazon.
Building out 93,000-square-foot "Green Wave" cultivation and processing facility in Montreal, Quebec.
BioGanix generates approximately $1M in revenue per quarter.
47 SKUs developed for BioGanix to date.
Acquiring Cannakids’s IP , a leader in medical "Green Wave" patient research and pediatric and adult consumer product development.
Pending Sleipnir acquisition will initially bring in US$500K to Relevium’s topline revenue.
Partnership in place with HempCo Canada.
International expansion plans for all brands.
Relevium In the News
Relevium’s Biocannabix Positions Itself as an Important Player in Colombia as it Pursues Endo-Medical Cannabis Strategy for Latin America
Earlier this month, RLVRelevium’s Biocannabix positioned itself as an important player in the Colombian medical cannabis market by cementing medical and research relationships in the country in order to establish clinical validation programs for its Endo Nutraceutical Supplements (ENS) and Oral Nutritional Supplements.
On June 13th, 2019, the Company announced a binding LOI to acquire LifeLine Pharma SAS , a binding agreement to acquire the shares of Lifeline Pharma SAS , a Cali based cultivation and extraction business in the burgeoning agro-pharma market in Colombia. With a much lower cost of production, a robust commercial and legal framework and a culture that is open to Phyto therapeutic medicine, Colombia is quickly becoming a global center of medical cannabis supply and it is forecasted that the Country will be looking to supply as much as 44% of the World’s demand.
“This is a major strategic step in the development of our Phyto therapeutic biopharma business” stated Aurelio Useche, CEO of Relevium Technologies.
The Company’s subsidiary, Biocannabix Health Corporation, is a vertically integrated medical cannabis company with strategic positioning in three major markets: Canada, Latin America and Europe.
The company’s operations in Montreal allows Biocannabix to leverage leading edge scientific and research platforms as well as government incentives in the province of Quebec. The recent acquisition of LifeLine in Colombia allows the company to leverage lower costs of cultivation and processing as well as to manage its own genetics for the production of targeted Phyto therapeutic formulations. Colombia, Canada and Germany combined are central to the clinical validation program for the ENS and ONS products that will be offered in all three markets.
Relevium Takes Major Step in Latam to Acquire Lifeline Pharma in Cali , Colombia
Biocannabix Health Corporation (“Biocannabix”), a wholly-owned subsidiary of Relevium has executed on June 12, 2019 a binding agreement to acquire the shares of Lifeline Pharma SAS , a Cali based cultivation and extraction business in the burgeoning agro pharma market in Colombia.
KEY HIGHLIGHTS OF THE PARTNERSHIP WITH LIFELINE
Best in class partnership for international vertical integration.
Combination of Biocannabix focus on Pediatric Endo-Medicine with a large-scale operation with 150 years of sustainable, environmentally responsible and organic agricultural history
Located in Rozo, Valle del Cauca, in the heart of the sugar cane enclave seven minutes away from the international airport and 10 minutes away from Cali’s downtown core and a population of over 3M people
Multi-stage project with (1) an initial 5 hectares that includes the local offices, a laboratory, a fully enclosed greenhouse for tissue culture and micropropagation and an initial cultivation of over 200,000 square feet in open air green houses, (2) an option to expand to an additional 20 hectares or 2.2 million square feet of open air greenhouse cultivation and (3) the possibility to expand to another additional 60 hectares or 6.5 million square feet of cultivation.
Full registration of 668 genetic strains with the ICA , the Instituto Colombiano Agropecuario.
Three licenses in progress including (1) extraction and manufacturing, (2) cultivation with THC and (3) non-psychoactive cultivation, all with scientific research, domestic sales and export modalities.
Strategic low-cost infrastructure that allows for an estimated stage two flower capacity of 170,000 Kg per year with an initial estimated cost of production 0.53$ per gram.
Development of an industrial scale extraction plant in the Pacific Free Zone, a private industrial park located minutes away from the cultivation project. The free zone offers the benefits of the free regime and seeks to promote and develop the process of industrialization of goods, the productive chain and the provision of services, as well as strengthen the competitiveness of its users and customers by taking advantage of the generated opportunities from international trade and bilateral agreements signed by Colombia.
Genetics laboratory and agronomic research in the BioParque del Pacifico located in the campus of the International Center for Tropical Agriculture (CIAT) and the Colombian Corporation for agricultural research (Agrosavia).
STRATEGIC FIT FOR GLOBAL SUPPLY AND VERTICAL INTEGRATION
Relevium’s Bio-Pharma arm, Biocannabix, is focused in developing, marketing and selling endo-medicinal formulations on Nutraceuticals and Medical foods aimed primarily to pediatrics. An essential component of the strategy of delivering safe, 100% auditable medicine for pediatric patients is to ensure total control over the genetics, the cultivation and the processing of extracts. The partnership with Lifeline ensures a 100% organically grown product with access to over 600 registered genetic strains, the buildout of an EU GMP extraction facility in the Pacific Free Zone and the ability to trace and fully audit the process from seed to medicine through blockchain technology.
The strict regulation of the Colombian legal regime for cannabis only allow for the export of extracts and finished goods and we aim to service international demand for organically sourced medical cannabis extracts for LATAM, Europe and eventually the Asian continent.
LOCAL MARKET THAT IS READY TO ADOPT ENDO-MEDICINAL FORMULATIONS
Traditional remedies and natural medicine are an integral part of Colombian culture and with a fast-growing middle class and entrepreneurial nature, this market with a population of over 49 million is moving quickly to adopt cannabinoid therapy. Lifeline, through Biocannabix pediatric formulations, is poised to successfully obtain a significant market share of the local market.
TRANSACTION DETAILS
Under the terms of the binding agreement, Biocannabix will acquire 100% of the shares on Lifeline Pharma SAS by investing an initial US$850,000 to be deployed during stage one of the projects. The initial investment is comprised of US$125,000 at signing, US$125,000 upon the grant of the initial licenses and a commitment to deploy funds totalling US$600,000 over the next seven months. As part of the transaction, Biocannabix Health Corporation will issue US$3,650,000 in shares representing approximately 41% of the shares outstanding of the wholly owned subsidiary.
In the event of a major transaction including a sale or a public offering, the shareholders of Lifeline Pharma will also receive an additional US$1.5 million to be settled in shares of Biocannabix or in cash.
Aurelio Useche, CEO of Relevium stated: “The acquisition and partnership with Lifeline Pharma SAS in Colombia represents the single most important development to date for Relevium, our team and our shareholders. This is the culmination of months of strategic re-alignment, negotiations and a lot of hard work by our team and the key stakeholders of Lifeline”. Mr. Useche added:” We are very pleased and proud to partner with the amazing team of Lifeline, including Oscar LIbreros CEO and Hossein Shadanlou COO and look forward to work together to execute on the common mission of providing safe, organically sourced and fully auditable endo-medicinal products for pediatric applications”
Oscar LIbreros, CEO of Lifeline Pharma SAS stated: “With over 150 years of tradition in organic farming and our objective to provide the best medical cannabis extracts and products, we are happy (THRILLED) to join forces and merge with Biocannabix Health Corporation in Canada. We look forward to delivering real value through the disciplined deployment of our operational strategy from Colombia to the world”
Cannabis Cultivation and Extraction Potentially Costs 80% Less in Latin America
With a much lower cost of production, a robust commercial and legal framework and a culture that is open to Phyto therapeutic medicine, Colombia is quickly becoming a global center of medical cannabis supply and it is forecasted that the Country will be looking to supply as much as 44% of the World's demand.
The region boasts exceptional climatic conditions, with lots of sunshine and good rainfall. This coupled with acres and acres of arable land, could make the LATAM region the global leaders in cannabis production.
In addition to the above, the price of labor is exceptionally cheap when compared to it's European and North American counterparts. Combined, it is estimated that LATAM will be able to produce cannabis – in commercial quantities – for nearly 80% less than the rest of the world. That's a pretty big advantage.
The recent acquisition of LifeLine in Colombia allows the company to leverage lower costs of cultivation and processing as well as to manage its own genetics for the production of targeted Phyto therapeutic formulations. Colombia, Canada and Germany combined are central to the clinical validation program for the ENS and ONS products that will be offered in all three markets.
The Bottom Line
RLLVF deserves your immediate attention
We suggest that you add this rapidly growing microcap cannabis company to the top of your watch-list, as these triggered technical indicators and company news could bring serious interest to this stock.
Best Regards,
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated three thousand dollars by MJ Capital LLC for an investor relations advertising marketing campaign w/ 2000 TradingView™ views for RLLVF. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
RLLVF to rally on Exclusivity Agreement with SOS Cannabis Inc
=====================
RLLVF (Relevium Technologies Inc.)
Current Price: $0.0592
Float: 122.64M
Website | Recent News
========================
Legal Cannabis is Expected to Grow 230%, to $31.3 Billion in 2022
Global spending on legal cannabis is expected to grow 230%, to $31.3 billion in 2022, compared to $9.5 billion in 2017, according to Arcview Market Research and BDS Analytics. The research suggests that most of that, nearly $23.4 billion, will be spent in the U.S. With more states voting for the legalization of marijuana and business interest sparking, that definitely makes sense.
Marijuana Regulation: The Facts
While Canada legalized marijuana in late 2018, it remains illegal under federal U.S. law and is still classified as a controlled substance without proven medical benefit, along with heroin and LSD. However, with some 30 states voting to make cannabis legal for medicinal use, recreational use, or both, marijuana regulation in the U.S. essentially is a hot mess.
30 states have approved the legalization of marijuana for medical or recreational use or both.
In 2018 alone, the following states voted in favor of marijuana legalization:
Michigan: Voters legalized marijuana use and cultivation for people over the age of 21 and authorized the commercial sale of marijuana through state-licensed retailers.
Missouri: Voters approved legalizing marijuana for medical purposes and allowing patients to cultivate plants at home.
Oklahoma: Voters approved legalizing marijuana for medical use.
Utah: Voters approved some use of marijuana for medical purposes.
Who are the Top Players in this Sector at the Moment
Canopy Growth Corp. ( CGC )
The first Canadian marijuana company, Canopy Growth Corp. is the world's largest publicly-traded weed company. The company owns and operates many brands, producing and marketing both medical and recreational strains. Tweed is one of the company's most popular brands, thanks to an association with rapper Snoop Dogg. For its 2019 fiscal year, it reported revenue of CAD 77.9 million or nearly $60 million.
In October 2017, Constellation Brands , the beverage giant, and maker of Corona beer bought a 9.9% stake in Canopy Growth. The deal offers both companies a chance at new product lines such as cannabis-infused beverages.
Aurora Cannabis Inc. ( ACB )
Another big Canadian pot company, Aurora Cannabis became even bigger in March by acquiring rival MedReleaf in a $250 million all-stock deal that was touted as the world's largest marijuana deal to date. Consolidating operations will help the new entity cut costs and gain efficiency. According to a press release, Aurora and MedReleaf together expect to produce over 570,000 kilograms per year of cannabis through nine facilities in Canada and two in Denmark.
Aurora debuted on the Canadian venture stock exchange (TSX) in October 2016 and trades in the U.S. on the NYSE.
Cronos Group Inc . ( CRON )
Nasdaq's first pot stock, Cronos Group is a Toronto-based cultivator of medical marijuana . In addition to Canada, Cronos serves international markets, shipping its products to Germany, building a facility in Israel, and starting a joint venture in Australia. Cronos Group does not have a presence in the U.S. due to the uncertainty in regulations.
As of its 2018 fiscal year, the company generated $7.3 million in revenue.
The Top Players Offer Little Upside Potential
Over the last 12 months, there has been tremendous hype on cannabis stocks. The widespread legalization in some states in the U.S. and all of Canada caused many stocks related to the pot industry to skyrocket, leaving little upside potential for investors late to the party.
However, there are still some juicy opportunities out there...
We've Found A Cannabis Stock That Still Has Plenty Of Room To Run
That company is Relevium Technologies, and it is publicly traded in three countries on three separate exchanges OTCQB: “RLLVF”, TSX.V: “RLV”, and Frankfurt: “6BX”.
Relevium Technologies is hitting on all cylinders from both a business and technical perspective, and they recently released some market friendly news that is sure to grab the attention of Wall Street.
The Company signed an exclusivity agreement to partner with SOS cannabis Inc. (“SOSCannabis”), which will provide pediatric customers with the ability to obtain free legal representation to seek reimbursement for the costs of medical cannabinoid therapy from different government agencies for the treatment of medical conditions for pediatric patients.
The partnership agreement will provide Relevium’s pediatric customers with access to an experienced legal and case management team, who will prepare the case file and seek retroactive and prospective reimbursement for parents of pediatric patients at no cost. The agreement provides Relevium with a unique advantage in terms of its business development strategy and first to market positioning in terms of pediatric applications.
Mr. Aurelio Useche, CEO of Relevium stated: “As we prepare to enter the pediatric endo-medicinal market in Canada with an initial ten (10) CannaKids® formulated products, not only are we providing parents with a natural alternative and/or health support mechanism, but now we are able to provide them with the ability to seek reimbursement from governmental agencies without any costs,” Mr. Useche stated further: “We are extremely happy to work with a team of caring legal professionals that can represent our customers in minimizing the financial burden of cannabinoid therapy.”
Maitre Robert Astell, President of SOSCannabis.com stated “We are delighted to welcome Relevium into our family of medicinal cannabinoid therapy suppliers. The focus and quest of Relevium in terms of pediatric patients is admirable and we look forward to onboarding parents into our fully-automated registration platform and to provide them with the state-of-the-art case management service in fulfilling their need for economic assistance in providing natural medicine to their children.”
Tracy Ryan, CEO of Cannakids® stated: “For years patients have struggled with the high expenses that come along with using cannabis as a medicine. Especially parents to sick children who often lose their jobs due to countless hospital stays and doctor’s appointments. This new opportunity for families is a major step in the right direction. We are elated that more will now have the opportunity to afford this powerful, non-toxic option that we have seen bring unimaginable relief to patients on a global scale.”
About Relevium Technologies
Relevium Technologies operates in the health and wellness industry, including legal cannabis, with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operations of brands and businesses in the health and wellness markets and medical cannabis. The Company pursues its business strategy through an acquisition and partnership model in a holistic approach to encompass a wide range of health and wellness consumer products.
Relevium’s products are part of the $3.72 trillion dollar global wellness industry — one of the fastest growing worldwide markets. Their specific focus is on products that promote overall health, nutraceuticals, fitness nutrition and cosmeceuticals. The company already has 25 products being sold on Amazon with more being planned.
Relevium operates through two wholly owned subsidiaries:
BGX E-Health LLC (BGX), based in Orlando, Florida, markets dietary supplements, nutraceuticals, sports nutrition and cosmeceuticals primarily through its Bioganix® brand portfolio in the US and Europe. Relevium’s premium brands are sold at some of the world’s largest retailers including such as Walmart.com and Amazon.com.
The company’s product offering includes cutting-edge line of weight-loss, anti-inflammatory, heart, vision, beauty and fitness supplements sold through their Bioganix®, Push & Pull System® and LeefyLyfe® brands with the objective of helping people lose weight, become healthier, happier, and most importantly achieve the results that our customers desire.
Bioganix®, founded in 2014, has some of the best-selling products in the Health and Personal Care category on Amazon, and a loyal customer base. The combination of online marketing with an emphasis on superior quality products backed by stringent scientific research and formulations, this has developed Bioganix® in becoming one of the leading dietary supplement brands online.
Push & Pull®, launched in 2019, is the first comprehensive natural anti-aging system for complete skin care that combines Collagen Protein supplements (PUSH) and naturally sourced Aloe Vera skin anti-aging cream (PULL). This new brand targets a brand-new revenue stream in the burgeoning cosmeceutical market, which is the fastest growing segment of the health and wellness Market.
LeefyLyfe® is their OTC cannabidiol Phyto formulated brand that combines the same trusted ingredients as those found in Bioganix® and Push & Pull® with the benefits of CBD . The company is currently waiting for the decision by the FDA to allow the sale of CBD as a supplement in order to release its products into the market.
Since 2017, Relevium’s OTC has grown its product offering and expanded its distribution channels to some of the largest online marketplaces such as eBay , Amazon and Walmart.com. Relevium will continue to innovate with the BioGanix brand, expand the product line and distribution channels to further drive growth.
Biocannabix Health Corporation (BCX), based in Montreal, Quebec, is a biopharma nutraceutical company focused on delivering pediatric endo-medicinal nutraceuticals for cannabinoid therapy.
The company combines leading biopharma expertise, agricultural and logistic advantages of Colombia and trusted brand status with a clinically validation process for Phyto therapeutic medical products aimed at pediatric applications.
Biocannabix’ vertically integrated operations are located in key markets around the world: Canada, Colombia and Germany.
Scientific and Administrative Offices located in Montreal, Quebec
Cultivation and Extraction operations with an initial 20 hectares located in Cali , Colombia
Distribution and compliance partnership in Germany
The portfolio of Biocannabix brands include:
Cannakids®: Pediatric brand exclusive for the Canadian market
Relevium Senior®: Geriatric brand targeting inflammatory conditions including joints, heart and brain.
Relevium Kids®: Pediatric brand of Nutraceuticals and Oral Nutritional Supplements
Investment Highlights:
In 2017, the global wellness market reached $4.2T.
Global nutraceutical market to reach US$578.23B by 2025.
Vast distribution network through industry giants like Walmart and Amazon.
Building out 93,000-square-foot "Green Wave" cultivation and processing facility in Montreal, Quebec.
BioGanix generates approximately $1M in revenue per quarter.
47 SKUs developed for BioGanix to date.
Acquiring Cannakids’s IP , a leader in medical "Green Wave" patient research and pediatric and adult consumer product development.
Pending Sleipnir acquisition will initially bring in US$500K to Relevium’s topline revenue.
Partnership in place with HempCo Canada.
International expansion plans for all brands.
Relevium In the News
Relevium’s Biocannabix Positions Itself as an Important Player in Colombia as it Pursues Endo-Medical Cannabis Strategy for Latin America
Earlier this month, RLVRelevium’s Biocannabix positioned itself as an important player in the Colombian medical cannabis market by cementing medical and research relationships in the country in order to establish clinical validation programs for its Endo Nutraceutical Supplements (ENS) and Oral Nutritional Supplements.
On June 13th, 2019, the Company announced a binding LOI to acquire LifeLine Pharma SAS , a binding agreement to acquire the shares of Lifeline Pharma SAS , a Cali based cultivation and extraction business in the burgeoning agro-pharma market in Colombia. With a much lower cost of production, a robust commercial and legal framework and a culture that is open to Phyto therapeutic medicine, Colombia is quickly becoming a global center of medical cannabis supply and it is forecasted that the Country will be looking to supply as much as 44% of the World’s demand.
“This is a major strategic step in the development of our Phyto therapeutic biopharma business” stated Aurelio Useche, CEO of Relevium Technologies.
The Company’s subsidiary, Biocannabix Health Corporation, is a vertically integrated medical cannabis company with strategic positioning in three major markets: Canada, Latin America and Europe.
The company’s operations in Montreal allows Biocannabix to leverage leading edge scientific and research platforms as well as government incentives in the province of Quebec. The recent acquisition of LifeLine in Colombia allows the company to leverage lower costs of cultivation and processing as well as to manage its own genetics for the production of targeted Phyto therapeutic formulations. Colombia, Canada and Germany combined are central to the clinical validation program for the ENS and ONS products that will be offered in all three markets.
Relevium Takes Major Step in Latam to Acquire Lifeline Pharma in Cali , Colombia
Biocannabix Health Corporation (“Biocannabix”), a wholly-owned subsidiary of Relevium has executed on June 12, 2019 a binding agreement to acquire the shares of Lifeline Pharma SAS , a Cali based cultivation and extraction business in the burgeoning agro pharma market in Colombia.
KEY HIGHLIGHTS OF THE PARTNERSHIP WITH LIFELINE
Best in class partnership for international vertical integration.
Combination of Biocannabix focus on Pediatric Endo-Medicine with a large-scale operation with 150 years of sustainable, environmentally responsible and organic agricultural history
Located in Rozo, Valle del Cauca, in the heart of the sugar cane enclave seven minutes away from the international airport and 10 minutes away from Cali’s downtown core and a population of over 3M people
Multi-stage project with (1) an initial 5 hectares that includes the local offices, a laboratory, a fully enclosed greenhouse for tissue culture and micropropagation and an initial cultivation of over 200,000 square feet in open air green houses, (2) an option to expand to an additional 20 hectares or 2.2 million square feet of open air greenhouse cultivation and (3) the possibility to expand to another additional 60 hectares or 6.5 million square feet of cultivation.
Full registration of 668 genetic strains with the ICA , the Instituto Colombiano Agropecuario.
Three licenses in progress including (1) extraction and manufacturing, (2) cultivation with THC and (3) non-psychoactive cultivation, all with scientific research, domestic sales and export modalities.
Strategic low-cost infrastructure that allows for an estimated stage two flower capacity of 170,000 Kg per year with an initial estimated cost of production 0.53$ per gram.
Development of an industrial scale extraction plant in the Pacific Free Zone, a private industrial park located minutes away from the cultivation project. The free zone offers the benefits of the free regime and seeks to promote and develop the process of industrialization of goods, the productive chain and the provision of services, as well as strengthen the competitiveness of its users and customers by taking advantage of the generated opportunities from international trade and bilateral agreements signed by Colombia.
Genetics laboratory and agronomic research in the BioParque del Pacifico located in the campus of the International Center for Tropical Agriculture (CIAT) and the Colombian Corporation for agricultural research (Agrosavia).
STRATEGIC FIT FOR GLOBAL SUPPLY AND VERTICAL INTEGRATION
Relevium’s Bio-Pharma arm, Biocannabix, is focused in developing, marketing and selling endo-medicinal formulations on Nutraceuticals and Medical foods aimed primarily to pediatrics. An essential component of the strategy of delivering safe, 100% auditable medicine for pediatric patients is to ensure total control over the genetics, the cultivation and the processing of extracts. The partnership with Lifeline ensures a 100% organically grown product with access to over 600 registered genetic strains, the buildout of an EU GMP extraction facility in the Pacific Free Zone and the ability to trace and fully audit the process from seed to medicine through blockchain technology.
The strict regulation of the Colombian legal regime for cannabis only allow for the export of extracts and finished goods and we aim to service international demand for organically sourced medical cannabis extracts for LATAM, Europe and eventually the Asian continent.
LOCAL MARKET THAT IS READY TO ADOPT ENDO-MEDICINAL FORMULATIONS
Traditional remedies and natural medicine are an integral part of Colombian culture and with a fast-growing middle class and entrepreneurial nature, this market with a population of over 49 million is moving quickly to adopt cannabinoid therapy. Lifeline, through Biocannabix pediatric formulations, is poised to successfully obtain a significant market share of the local market.
TRANSACTION DETAILS
Under the terms of the binding agreement, Biocannabix will acquire 100% of the shares on Lifeline Pharma SAS by investing an initial US$850,000 to be deployed during stage one of the projects. The initial investment is comprised of US$125,000 at signing, US$125,000 upon the grant of the initial licenses and a commitment to deploy funds totalling US$600,000 over the next seven months. As part of the transaction, Biocannabix Health Corporation will issue US$3,650,000 in shares representing approximately 41% of the shares outstanding of the wholly owned subsidiary.
In the event of a major transaction including a sale or a public offering, the shareholders of Lifeline Pharma will also receive an additional US$1.5 million to be settled in shares of Biocannabix or in cash.
Aurelio Useche, CEO of Relevium stated: “The acquisition and partnership with Lifeline Pharma SAS in Colombia represents the single most important development to date for Relevium, our team and our shareholders. This is the culmination of months of strategic re-alignment, negotiations and a lot of hard work by our team and the key stakeholders of Lifeline”. Mr. Useche added:” We are very pleased and proud to partner with the amazing team of Lifeline, including Oscar LIbreros CEO and Hossein Shadanlou COO and look forward to work together to execute on the common mission of providing safe, organically sourced and fully auditable endo-medicinal products for pediatric applications”
Oscar LIbreros, CEO of Lifeline Pharma SAS stated: “With over 150 years of tradition in organic farming and our objective to provide the best medical cannabis extracts and products, we are happy (THRILLED) to join forces and merge with Biocannabix Health Corporation in Canada. We look forward to delivering real value through the disciplined deployment of our operational strategy from Colombia to the world”
Cannabis Cultivation and Extraction Potentially Costs 80% Less in Latin America
With a much lower cost of production, a robust commercial and legal framework and a culture that is open to Phyto therapeutic medicine, Colombia is quickly becoming a global center of medical cannabis supply and it is forecasted that the Country will be looking to supply as much as 44% of the World's demand.
The region boasts exceptional climatic conditions, with lots of sunshine and good rainfall. This coupled with acres and acres of arable land, could make the LATAM region the global leaders in cannabis production.
In addition to the above, the price of labor is exceptionally cheap when compared to it's European and North American counterparts. Combined, it is estimated that LATAM will be able to produce cannabis – in commercial quantities – for nearly 80% less than the rest of the world. That's a pretty big advantage.
The recent acquisition of LifeLine in Colombia allows the company to leverage lower costs of cultivation and processing as well as to manage its own genetics for the production of targeted Phyto therapeutic formulations. Colombia, Canada and Germany combined are central to the clinical validation program for the ENS and ONS products that will be offered in all three markets.
The Bottom Line
RLLVF deserves your immediate attention
We suggest that you add this rapidly growing microcap cannabis company to the top of your watch-list, as these triggered technical indicators and company news could bring serious interest to this stock.
Best Regards,
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated three thousand dollars by MJ Capital LLC for an investor relations advertising marketing campaign w/ 2000 TradingView™ views for RLLVF. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
Bullish on Bed Baths great reversal.
Reversals like today's in NASDAQ:BBBY can not be ignored, as a result of mixed earnings and overreaction by the algos the stock plummeted on the open, hit support and bang, it never looked back, buyers jumped in and considering this stock carries a 40% short interest it may not be over, this looks like offering more rewards to the longs.
Bullish on Bed Baths great reversal.
Reversals like today's in NASDAQ:BBBY can not be ignored, as a result of mixed earnings and overreaction by the algos the stock plummeted on the open, hit support and bang, it never looked back, buyers jumped in and considering this stock carries a 40% short interest it may not be over, this looks like offering more rewards to the longs.
Unusual Accumulation in EVOKE PHARMA INC. Keep watch
Keep on your watchlist for continuation in price action and buy side volume , looks like accumulation is underway and the fact it is a Pharmaceutical stock, Trial data or FDA releases could be the stimulus.
Very speculative, but very rewarding trade setup on the chart.
COMPANY PROFILE
Evoke Pharma , Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.
Unusual Accumulation in EVOKE PHARMA INC. Keep watch
Keep on your watchlist for continuation in price action and buy side volume , looks like accumulation is underway and the fact it is a Pharmaceutical stock, Trial data or FDA releases could be the stimulus.
Very speculative, but very rewarding trade setup on the chart.
COMPANY PROFILE
Evoke Pharma , Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.
PWDY is up +80% on massive early volume and could run even more!
========================
Powerdyne International Inc.
OTCBB: PWDY
Current Price: $0.0009
+100%
WEBSITE
=======================
PWDY is up +80% on massive early volume and could run even more!
Is that something that you would be interested in getting on board with?
If so and if you haven't already, we ask that you turn your immediate attention to
POWERDYNE INTERNATIONAL INC.
An Epic Bounce in the Making for this Low-Float Alert
Powerdyne International was organized to provide independent, cost efficient primary electrical power. PDI will materially reduce the complexities of electric power requirements with focus on cost savings and a guarantee of power quality for the user.
PWDY leases self-contained electrical generation units, the PDI Power Solution. Every PDI Power Solution is a customized green generator set designed to meet the client’s unique power requirements including the options for cogeneration (CHPC) and micro grids.
PWDY is staffed by individuals with experience in manufacture, marketing and sales of quality, renewable power systems. In addition for compliance and greater market acceptance the PDI Genset would use only gaseous fuels – natural gas and propane would dominate.
The electrical power market is vast and grid power dominates it. However, there are avenues open to providers such as PDI to bypass the grid and thousands of substations. There are users who have an interest in reducing dependency upon and/or elimination of the grid entirely. PDI enters as the total primary power provider, including flexibility with product customization and jointly acceptable long term power purchase agreements.
Powerdyne International, Inc. Portable Power Solutions
PWDY Is a manufacturing company that builds and leases electrical generation equipment including its own portable electrical power generation equipment called PDI Genset (which is patent and trademark pending).
PDI Gensets are designed to be installed at virtually any location. The genset is leased and maintained by PDI. Although the company's target customer will typically use its PDI Genset to produce its own primary electrical power, it can be used for emergency back-up power generation and is useful in any situation where reliable power is needed.
PDI is founded on the ability to produce primary electrical power using proprietary technology to power electrical generation equipment which makes electricity cheaper than existing means of producing primary electric power. PDI expects that the difference between its cost of generating electricity over its customer's current cost will result in substantial savings to the customer.
For more information http://www.PowerdyneInternational.com
A PATENT THAT HOLDS SERIOUS UPSIDE POTENTIAL
PWDY took an existing technology and modified it to develop a solid state, self-contained genset that runs efficiently on natural gas , propane, methane, ethane and hydrogen. The PDI Genset technology was invented by Powerdyne International, Inc. (which is patent and trademark pending).
Being that it is patent and trademark are pending, PDI still shows massive upside potential in regards to share price.
This undervalued stock is at its 52 week low, and should be on your radar tomorrow.
We see tons of upside potential from here, and anticipate a huge bounceback from PWDY today.
We are asking all of our members to start their research on PWDY immediately, and consider building a position.
You can now join our Free SMS Text Alert Service using the quick and easy process below to guarantee that you receive our trade alerts the second they are released.
i
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by Shore Thing Media, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to Shore Thing Media, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. Shore Thing Media does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future.
Shore Thing Media’s business model is to receive financial compensation to promote public companies. We have not been compensated to conduct investor relations advertising or marketing on PWDY. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, Shore Thing Media often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
PWDY is up +80% on massive early volume and could run even more!
========================
Powerdyne International Inc.
OTCBB: PWDY
Current Price: $0.0009
+100%
WEBSITE
=======================
PWDY is up +80% on massive early volume and could run even more!
Is that something that you would be interested in getting on board with?
If so and if you haven't already, we ask that you turn your immediate attention to
POWERDYNE INTERNATIONAL INC.
An Epic Bounce in the Making for this Low-Float Alert
Powerdyne International was organized to provide independent, cost efficient primary electrical power. PDI will materially reduce the complexities of electric power requirements with focus on cost savings and a guarantee of power quality for the user.
PWDY leases self-contained electrical generation units, the PDI Power Solution. Every PDI Power Solution is a customized green generator set designed to meet the client’s unique power requirements including the options for cogeneration (CHPC) and micro grids.
PWDY is staffed by individuals with experience in manufacture, marketing and sales of quality, renewable power systems. In addition for compliance and greater market acceptance the PDI Genset would use only gaseous fuels – natural gas and propane would dominate.
The electrical power market is vast and grid power dominates it. However, there are avenues open to providers such as PDI to bypass the grid and thousands of substations. There are users who have an interest in reducing dependency upon and/or elimination of the grid entirely. PDI enters as the total primary power provider, including flexibility with product customization and jointly acceptable long term power purchase agreements.
Powerdyne International, Inc. Portable Power Solutions
PWDY Is a manufacturing company that builds and leases electrical generation equipment including its own portable electrical power generation equipment called PDI Genset (which is patent and trademark pending).
PDI Gensets are designed to be installed at virtually any location. The genset is leased and maintained by PDI. Although the company's target customer will typically use its PDI Genset to produce its own primary electrical power, it can be used for emergency back-up power generation and is useful in any situation where reliable power is needed.
PDI is founded on the ability to produce primary electrical power using proprietary technology to power electrical generation equipment which makes electricity cheaper than existing means of producing primary electric power. PDI expects that the difference between its cost of generating electricity over its customer's current cost will result in substantial savings to the customer.
For more information http://www.PowerdyneInternational.com
A PATENT THAT HOLDS SERIOUS UPSIDE POTENTIAL
PWDY took an existing technology and modified it to develop a solid state, self-contained genset that runs efficiently on natural gas , propane, methane, ethane and hydrogen. The PDI Genset technology was invented by Powerdyne International, Inc. (which is patent and trademark pending).
Being that it is patent and trademark are pending, PDI still shows massive upside potential in regards to share price.
This undervalued stock is at its 52 week low, and should be on your radar tomorrow.
We see tons of upside potential from here, and anticipate a huge bounceback from PWDY today.
We are asking all of our members to start their research on PWDY immediately, and consider building a position.
You can now join our Free SMS Text Alert Service using the quick and easy process below to guarantee that you receive our trade alerts the second they are released.
i
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by Shore Thing Media, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to Shore Thing Media, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. Shore Thing Media does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future.
Shore Thing Media’s business model is to receive financial compensation to promote public companies. We have not been compensated to conduct investor relations advertising or marketing on PWDY. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, Shore Thing Media often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
ANFI has bottomed out and is ready to bounce hard.
=====================
ANFI ( Amira Nature Foods Ltd .)
Float: 25.82M
Alert Price: $0.7034
Target Price: $6.00
Chart Analysis
Investor Presentation
Investor Webcast
Website | Recent News
========================
Members,
We are following up today's +15% winner with an NYSE listed company that could see its share price more than double in the immediate future.
We ask that you immediately add ANFI ( Amira Nature Foods Ltd .) to the top of your watchlist.
This ticker has provided our members with several opportunities to profit each and everytime we have brought it to your attention.
June 20th: +8.54% Gain!
June 17th: +17% Gain!
March 14th: +62.28% Gain! (Multi-Day)
And let's not forget about ANFI's epic bull run earlier this year, in which members secured up to +320% in long-term profits as it ran from $0.44 to $1.85!
There are obviously no guarantees on Wall St ., but ANFI has been as close to a sure a thing as we have ever seen.
This is by far the most attractive entry point that we have ever alerted ANFI at,
ANFI is currently trading near the lower end of its 52-week price channel , but in our opinion that just means its upside potential far outweighs any downside risk!
We've done our very own chart analysis and we believe that a bullish reversal is just beginning to shape up.
In fact we see the potential for a move of over +77%!
Especially since the Company has recently made some market friendly announcements that we believe will serve as huge catalysts for a bullish uptrend
Signed a new contract to supply rice to a customer in the Europe, Middle East, and Africa (“EMEA”) region in the amount of $6 million. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020.
This along with their previously announced customer orders, amounts to over $57mn in revenue. This equates to securing 29% of our forecasted $200mn of FY2020 revenue just 63 days (17%) into the fiscal year”, stated Karan A. Chanana, Amira’s Chairman.
Announced the hiring of Brian M. Speck as Chief Financial Officer. With his many years of U.S. public company accounting experience Mr. Speck will assist ANFI in Westernizing their finance department as they focus on the international growth of their brands.
Entered into contracts, which consist of approximately $9 million in revenue, to supply rice and institutional products to new customers in the Europe, Middle East, and Africa (“EMEA”) and Asia regions.
ANFI's recent strategic moves have us extremely bullish on this past triple-digit winner.
But we're not the only ones...
Top 10 Wealth Firm Puts $6.00 Price Target on a $0.70 Stock
Jefferies analyst Akshay Jagdale recently maintained his Buy rating on ANFI and set a price target of $6.
That's an upside of +757% from today's alert price!
If you go to Google and search for the "Top 10 Wealth Firms" you'll notice that " Jefferies Wealth Management" is in the top 10 in the country.
If that wasn't enough to have you sold on ANFI , you'll be happy to know that Jefferies isn't the only equity research firm that is bullish on ANFI ...
Diamond Equity Research, a leading equity research and corporate access firm with a focus on small capitalization public companies recently initiated coverage on ANFI , and slapped on a $4.00 price target!
That's well over +471% in upside potential from today's alert price.
Their full research report is available here.
To say that ANFI is undervalued at its current share price would be the understatement of the year.
Here are a few other catalysts that coud have ANFI trading back over $1.00 in no time:
Low float of just 25.82M
Listed on the NYSE (High Liquidity)
Products now available on Amazon in the United Kingdom. The Company is initially offering its Brown Basmati Rice 2kg product and is looking forward to adding more products.
Reiterated its $200 million revenue guidance for the 2020 fiscal year ending March 31, 2020. Going forward, the Company’s focus will be on strengthening its international business and as such the 2020 fiscal year $200 million revenue guidance consists solely of international revenue (ex-India).
Jefferies analyst Akshay Jagdale recently maintained his Buy rating on ANFI and set a price target of $6.
Trading well below its average analyst price target of $6.00 (+630% Upside)
Its previously announced $30 million contract to supply third party branded basmati rice to a repeat customer in the Europe, Middle East, and Africa (“EMEA”) region was increased to $42 million within the provisions of the contract. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020.
It's Indian subsidiary, Amira Foods India (“Amira India”), has converted Amira India debt into ordinary shares of Amira India. As a result of the debt conversion, the Company’s ownership in Amira India decreased from 80.4% to 49.8%. This event is a continuation of Amira’s focus on strengthening the Company’s international business.
It is our opinion that ANFI is shaping up to be one of the top growth/value plays listed on the NYSE at the moment.
As such, we ask that all members start their research on ANFI immediately, and consider building a position tomorrow morning at 9:30AM EST
About Amira Nature Foods
Founded in 1915, Amira has evolved into a global provider of packaged Indian specialty rice, with sales in over 40 countries today. Amira sells Basmati rice, premium long-grain rice grown only in certain regions of the Indian sub-continent, under their flagship Amira brand as well as under other third party brands. Amira sells its products primarily in emerging markets through a broad distribution network. Amira’s headquarters are in Dubai, United Arab Emirates, and it also has offices in India, Germany, the United Kingdom, and the United States.
Company Highlights:
Large Staple Consumer Category with Highly Supportive Industry and Sub Category Fundamentals
A Market Lead with Differentiated Business Model
Globally Diversified with Wide Customer Base and Broad Product Portfolio
Vertically Integrated "State-of-the-art" Supply Chain and Operations
Strong Financial Track Record, Underpinned by Stable Margins
Highly Experienced and Successful Management Team
Announced that its previously announced $30 million contract to supply third party branded basmati rice to a repeat customer in the Europe, Middle East, and Africa (“EMEA”) region was increased to $42 million within the provisions of the contract. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020.
Since its founding in 1915, Amira has evolved from a domestic, family owned Indian business to a professionally managed, global branded, publicly traded, growing packaged food company.
Not only is the stock potentially undervalued based on its revenues and earnings , ANFI is also trading well below its book value, with a price-to-book ratio of 0.10, while the industry average is 1.81.
With ANFI trading well below the industry average for some key valuation ratios, it could be a value play, and could even attract potential buyers.
Moreover, Amira was able to increase at a compound annual growth rate of 15.5% between 2010 and 2017. With such high revenue growth rates, this company could be significantly undervalued by the market.
According to Finviz, over 50% of the company is owned by insiders. That in mind, that shows that the company’s officers, directors, and key insiders are confident in the company.
The Company has received numerous accolades:
Since 2010, Amira has been recognized in multiple years by the World Economic Forum as a “Global Growth Company”, an
invitation-only community consisting of ~300 of the world’s fastest-growing corporations
The World Consulting & Research Corporation named Amira one of “Asia’s Most Promising Brands”
Planman Marcom voted Amira the “INDIAN POWERBRAND” in the Food Category in 2011 and 2013
Amir was voted best partner in the “Staples” category in 2013 at the Bharti Walmart Private Limited Annual Supplier Conference
VWP World Brand recognized the Amira Brand as “The Admired Brand of India” in 2014–2015
Inc. India featured Amira as one of India’s fastest growing mid-sized companies in 2010, 2011, 2012 and 2013
Product Portfolio
Approximately three quarters of sales come from Basmati rice, the core focus of the company;
Sells more than 20 owned brands globally, spanning numerous price points;
Amira in India
Amira has established 15 Company managed distribution centers in India to provide it greater control over its expansion efforts in its home country location.
Amira is one of a handful of large relevant players in the domestic India market.
Amira represents a meaningful opportunity to consolidate the market over time.
Business Is Growing, Strategic Moves Will Expedite Growth
Amira Foods is no startup. The international business is healthy and generated roughly $270 million in sales in 2018. Those numbers are coupled with respectable margins that rested at 14.3% of gross sales. However, the company expects to do better with the expectation to add an additional 100bp to the international margins. Notably, there will some be shrinkage to the margins, which may be adjusted lower to account for the separation of the Indian business, due to less vertical integration and less sourcing from the primary processor. However, even with the expected reductions in the margin and certain efficiencies, analysts are pointing to ANFI being able to maintain separate sales of roughly $200 million, albeit with a lower margin of approximately 650bp. However, even with the expected short-term declines, the assumption of the lesser $200 million in sales coupled with an EBITDA margin of an expected 8.8%, can imply that ANFI will generate a positive EBITDA run of roughly $17 million. And, that is a healthy number to build upon.
Source: https://seekingalpha.com/instablog/49294...
Recent Developments
Appointment of Thomas Dennhardt (formerly Lidl) to CEO of Amira Basmati Rice GmbH (German subsidiary)
Board appointment of Hervé Larren (formerly LVMH), bringing experience in building brands internationally
EUR25mn Debt raise at 8.5% interest rate (due December 2023)
Reduced ownership of India subsidiary to 49.8%
Regains Compliance with NYSE Listing Requirements
Amira Nature Foods Ltd Announces New Contract of $6 Million
Earlier this month ANFI announced a new contract to supply rice to a customer in the Europe, Middle East, and Africa (“EMEA”) region in the amount of $6 million. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020.
“We are extremely pleased to announce this development, which along with our previously announced customer orders, amounts to over $57mn in revenue. This equates to securing 29% of our forecasted $200mn of FY2020 revenue just 63 days (17%) into the fiscal year”, stated Karan A. Chanana, Amira’s Chairman.
Further information on the Company, including an updated investor presentation and other information, can be found on the Company’s website at http://www.amira.net.
Market Outlook:
Amira operates in the global packaged rice market and is a leading provider of Basmati rice, a long-grain aromatic rice with favorable health attributes that can be grown only in specific regions of the Indian sub-continent and part of the Punjab region located in Pakistan. The global rice market is an enormous market with stable growth, while specialty rice and specifically Basmati rice benefits from premium pricing and increasing consumption patterns. Demand for Basmati rice has remained strong over the past 10 years due to the increased consumption trends both in India and internationally. Leading players such as McCormick & Co., Hain Celestial, Rice 'n Spice, LT Foods , East End Foods , and Amira Nature Foods serve local as well as global consumers, which is reflected in the growth of Basmati rice market. The size of worldwide Basmati rice market was approximately $10.51 Billion in 2017 and is estimated to be worth $17.74 Billion by the end of 2022, with a robust CAGR of 11% between 2017 and 2022, according to Transparency Market Research (TMR).
Rice is a $275bn Global Staple Category with Favorable Market Conditions
Rice is the primary staple for >50% of the world’s population and provides > 20% of the global caloric intake
Represents 30% of caloric consumption in Asia(4)
Defensive and non-cyclical with steady growth
Improves with age and has an extremely long shelf life (up to 5+ years) if stored properly
Global rice consumption is growing, estimated to reach c.483 million metric tonnes in 2017(5)
The global rice market is estimated at $275B and has grown at 2% volume CAGR over the 2010 – 2015 period
Technical Analysis
As we stated above, we've done our very own chart analysis and see the potential for a move of over +77% from here!
We see a positive reversal from long-term support right here, and a positive cross looks imminent.
The float of ANFI is extremely low for a NYSE listed company at just 25.82M.
We know this ticker can make big moves on volume , so we wouldn't be too surprised if this ticker starts to breakout early.
With its bullish $6.00 price target, we believe its upside potential far outweighs any downside risk.
The Bottom Line
ANFI has proven its ability run-up big in both the short and long-term.
ANFI has the potential to be the biggest gainer on the NYSE, and deserves to be on the top of your watchlist.
That being said, we ask that all members start their research on ANFI immediately, and consider building a position tomorrow morning at 9:30AM EST
(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned here within, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated fifteen thousand dollars by World Wide Holdings dba Invictus Resources for a 1-day investor relations advertising marketing campaign w/ 1000 TradingView™ views for ANFI . We have previously been compensated ten thousand dollars by World Wide Holdings dba Invictus Resources In LLC to conduct investor relations advertising and marketing for ANFI on five separate occasions which have expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
ANFI has bottomed out and is ready to bounce hard.
=====================
ANFI ( Amira Nature Foods Ltd .)
Float: 25.82M
Alert Price: $0.7034
Target Price: $6.00
Chart Analysis
Investor Presentation
Investor Webcast
Website | Recent News
========================
Members,
We are following up today's +15% winner with an NYSE listed company that could see its share price more than double in the immediate future.
We ask that you immediately add ANFI ( Amira Nature Foods Ltd .) to the top of your watchlist.
This ticker has provided our members with several opportunities to profit each and everytime we have brought it to your attention.
June 20th: +8.54% Gain!
June 17th: +17% Gain!
March 14th: +62.28% Gain! (Multi-Day)
And let's not forget about ANFI's epic bull run earlier this year, in which members secured up to +320% in long-term profits as it ran from $0.44 to $1.85!
There are obviously no guarantees on Wall St ., but ANFI has been as close to a sure a thing as we have ever seen.
This is by far the most attractive entry point that we have ever alerted ANFI at,
ANFI is currently trading near the lower end of its 52-week price channel , but in our opinion that just means its upside potential far outweighs any downside risk!
We've done our very own chart analysis and we believe that a bullish reversal is just beginning to shape up.
In fact we see the potential for a move of over +77%!
Especially since the Company has recently made some market friendly announcements that we believe will serve as huge catalysts for a bullish uptrend
Signed a new contract to supply rice to a customer in the Europe, Middle East, and Africa (“EMEA”) region in the amount of $6 million. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020.
This along with their previously announced customer orders, amounts to over $57mn in revenue. This equates to securing 29% of our forecasted $200mn of FY2020 revenue just 63 days (17%) into the fiscal year”, stated Karan A. Chanana, Amira’s Chairman.
Announced the hiring of Brian M. Speck as Chief Financial Officer. With his many years of U.S. public company accounting experience Mr. Speck will assist ANFI in Westernizing their finance department as they focus on the international growth of their brands.
Entered into contracts, which consist of approximately $9 million in revenue, to supply rice and institutional products to new customers in the Europe, Middle East, and Africa (“EMEA”) and Asia regions.
ANFI's recent strategic moves have us extremely bullish on this past triple-digit winner.
But we're not the only ones...
Top 10 Wealth Firm Puts $6.00 Price Target on a $0.70 Stock
Jefferies analyst Akshay Jagdale recently maintained his Buy rating on ANFI and set a price target of $6.
That's an upside of +757% from today's alert price!
If you go to Google and search for the "Top 10 Wealth Firms" you'll notice that " Jefferies Wealth Management" is in the top 10 in the country.
If that wasn't enough to have you sold on ANFI , you'll be happy to know that Jefferies isn't the only equity research firm that is bullish on ANFI ...
Diamond Equity Research, a leading equity research and corporate access firm with a focus on small capitalization public companies recently initiated coverage on ANFI , and slapped on a $4.00 price target!
That's well over +471% in upside potential from today's alert price.
Their full research report is available here.
To say that ANFI is undervalued at its current share price would be the understatement of the year.
Here are a few other catalysts that coud have ANFI trading back over $1.00 in no time:
Low float of just 25.82M
Listed on the NYSE (High Liquidity)
Products now available on Amazon in the United Kingdom. The Company is initially offering its Brown Basmati Rice 2kg product and is looking forward to adding more products.
Reiterated its $200 million revenue guidance for the 2020 fiscal year ending March 31, 2020. Going forward, the Company’s focus will be on strengthening its international business and as such the 2020 fiscal year $200 million revenue guidance consists solely of international revenue (ex-India).
Jefferies analyst Akshay Jagdale recently maintained his Buy rating on ANFI and set a price target of $6.
Trading well below its average analyst price target of $6.00 (+630% Upside)
Its previously announced $30 million contract to supply third party branded basmati rice to a repeat customer in the Europe, Middle East, and Africa (“EMEA”) region was increased to $42 million within the provisions of the contract. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020.
It's Indian subsidiary, Amira Foods India (“Amira India”), has converted Amira India debt into ordinary shares of Amira India. As a result of the debt conversion, the Company’s ownership in Amira India decreased from 80.4% to 49.8%. This event is a continuation of Amira’s focus on strengthening the Company’s international business.
It is our opinion that ANFI is shaping up to be one of the top growth/value plays listed on the NYSE at the moment.
As such, we ask that all members start their research on ANFI immediately, and consider building a position tomorrow morning at 9:30AM EST
About Amira Nature Foods
Founded in 1915, Amira has evolved into a global provider of packaged Indian specialty rice, with sales in over 40 countries today. Amira sells Basmati rice, premium long-grain rice grown only in certain regions of the Indian sub-continent, under their flagship Amira brand as well as under other third party brands. Amira sells its products primarily in emerging markets through a broad distribution network. Amira’s headquarters are in Dubai, United Arab Emirates, and it also has offices in India, Germany, the United Kingdom, and the United States.
Company Highlights:
Large Staple Consumer Category with Highly Supportive Industry and Sub Category Fundamentals
A Market Lead with Differentiated Business Model
Globally Diversified with Wide Customer Base and Broad Product Portfolio
Vertically Integrated "State-of-the-art" Supply Chain and Operations
Strong Financial Track Record, Underpinned by Stable Margins
Highly Experienced and Successful Management Team
Announced that its previously announced $30 million contract to supply third party branded basmati rice to a repeat customer in the Europe, Middle East, and Africa (“EMEA”) region was increased to $42 million within the provisions of the contract. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020.
Since its founding in 1915, Amira has evolved from a domestic, family owned Indian business to a professionally managed, global branded, publicly traded, growing packaged food company.
Not only is the stock potentially undervalued based on its revenues and earnings , ANFI is also trading well below its book value, with a price-to-book ratio of 0.10, while the industry average is 1.81.
With ANFI trading well below the industry average for some key valuation ratios, it could be a value play, and could even attract potential buyers.
Moreover, Amira was able to increase at a compound annual growth rate of 15.5% between 2010 and 2017. With such high revenue growth rates, this company could be significantly undervalued by the market.
According to Finviz, over 50% of the company is owned by insiders. That in mind, that shows that the company’s officers, directors, and key insiders are confident in the company.
The Company has received numerous accolades:
Since 2010, Amira has been recognized in multiple years by the World Economic Forum as a “Global Growth Company”, an
invitation-only community consisting of ~300 of the world’s fastest-growing corporations
The World Consulting & Research Corporation named Amira one of “Asia’s Most Promising Brands”
Planman Marcom voted Amira the “INDIAN POWERBRAND” in the Food Category in 2011 and 2013
Amir was voted best partner in the “Staples” category in 2013 at the Bharti Walmart Private Limited Annual Supplier Conference
VWP World Brand recognized the Amira Brand as “The Admired Brand of India” in 2014–2015
Inc. India featured Amira as one of India’s fastest growing mid-sized companies in 2010, 2011, 2012 and 2013
Product Portfolio
Approximately three quarters of sales come from Basmati rice, the core focus of the company;
Sells more than 20 owned brands globally, spanning numerous price points;
Amira in India
Amira has established 15 Company managed distribution centers in India to provide it greater control over its expansion efforts in its home country location.
Amira is one of a handful of large relevant players in the domestic India market.
Amira represents a meaningful opportunity to consolidate the market over time.
Business Is Growing, Strategic Moves Will Expedite Growth
Amira Foods is no startup. The international business is healthy and generated roughly $270 million in sales in 2018. Those numbers are coupled with respectable margins that rested at 14.3% of gross sales. However, the company expects to do better with the expectation to add an additional 100bp to the international margins. Notably, there will some be shrinkage to the margins, which may be adjusted lower to account for the separation of the Indian business, due to less vertical integration and less sourcing from the primary processor. However, even with the expected reductions in the margin and certain efficiencies, analysts are pointing to ANFI being able to maintain separate sales of roughly $200 million, albeit with a lower margin of approximately 650bp. However, even with the expected short-term declines, the assumption of the lesser $200 million in sales coupled with an EBITDA margin of an expected 8.8%, can imply that ANFI will generate a positive EBITDA run of roughly $17 million. And, that is a healthy number to build upon.
Source: https://seekingalpha.com/instablog/49294...
Recent Developments
Appointment of Thomas Dennhardt (formerly Lidl) to CEO of Amira Basmati Rice GmbH (German subsidiary)
Board appointment of Hervé Larren (formerly LVMH), bringing experience in building brands internationally
EUR25mn Debt raise at 8.5% interest rate (due December 2023)
Reduced ownership of India subsidiary to 49.8%
Regains Compliance with NYSE Listing Requirements
Amira Nature Foods Ltd Announces New Contract of $6 Million
Earlier this month ANFI announced a new contract to supply rice to a customer in the Europe, Middle East, and Africa (“EMEA”) region in the amount of $6 million. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020.
“We are extremely pleased to announce this development, which along with our previously announced customer orders, amounts to over $57mn in revenue. This equates to securing 29% of our forecasted $200mn of FY2020 revenue just 63 days (17%) into the fiscal year”, stated Karan A. Chanana, Amira’s Chairman.
Further information on the Company, including an updated investor presentation and other information, can be found on the Company’s website at http://www.amira.net.
Market Outlook:
Amira operates in the global packaged rice market and is a leading provider of Basmati rice, a long-grain aromatic rice with favorable health attributes that can be grown only in specific regions of the Indian sub-continent and part of the Punjab region located in Pakistan. The global rice market is an enormous market with stable growth, while specialty rice and specifically Basmati rice benefits from premium pricing and increasing consumption patterns. Demand for Basmati rice has remained strong over the past 10 years due to the increased consumption trends both in India and internationally. Leading players such as McCormick & Co., Hain Celestial, Rice 'n Spice, LT Foods , East End Foods , and Amira Nature Foods serve local as well as global consumers, which is reflected in the growth of Basmati rice market. The size of worldwide Basmati rice market was approximately $10.51 Billion in 2017 and is estimated to be worth $17.74 Billion by the end of 2022, with a robust CAGR of 11% between 2017 and 2022, according to Transparency Market Research (TMR).
Rice is a $275bn Global Staple Category with Favorable Market Conditions
Rice is the primary staple for >50% of the world’s population and provides > 20% of the global caloric intake
Represents 30% of caloric consumption in Asia(4)
Defensive and non-cyclical with steady growth
Improves with age and has an extremely long shelf life (up to 5+ years) if stored properly
Global rice consumption is growing, estimated to reach c.483 million metric tonnes in 2017(5)
The global rice market is estimated at $275B and has grown at 2% volume CAGR over the 2010 – 2015 period
Technical Analysis
As we stated above, we've done our very own chart analysis and see the potential for a move of over +77% from here!
We see a positive reversal from long-term support right here, and a positive cross looks imminent.
The float of ANFI is extremely low for a NYSE listed company at just 25.82M.
We know this ticker can make big moves on volume , so we wouldn't be too surprised if this ticker starts to breakout early.
With its bullish $6.00 price target, we believe its upside potential far outweighs any downside risk.
The Bottom Line
ANFI has proven its ability run-up big in both the short and long-term.
ANFI has the potential to be the biggest gainer on the NYSE, and deserves to be on the top of your watchlist.
That being said, we ask that all members start their research on ANFI immediately, and consider building a position tomorrow morning at 9:30AM EST
(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned here within, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated fifteen thousand dollars by World Wide Holdings dba Invictus Resources for a 1-day investor relations advertising marketing campaign w/ 1000 TradingView™ views for ANFI . We have previously been compensated ten thousand dollars by World Wide Holdings dba Invictus Resources In LLC to conduct investor relations advertising and marketing for ANFI on five separate occasions which have expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
BTC Retracement In Progress
4th wave of BTC in progress on this retracement. Feels ugly but it seems pretty normal at the moment.
Wait for the turn and look at possible long position in the dip. Seems to be respecting the technicals at the moment.
USD pairings on alt-coins have been hit hard though. People are dumping their coins for BTC at the moment.
BTC Retracement In Progress
4th wave of BTC in progress on this retracement. Feels ugly but it seems pretty normal at the moment.
Wait for the turn and look at possible long position in the dip. Seems to be respecting the technicals at the moment.
USD pairings on alt-coins have been hit hard though. People are dumping their coins for BTC at the moment.
Possible Wave Failure On ETH
Need to be careful here, possible wave failure on ETH is likely if this 4th wave keeps on going, it will ignore the Elliot Wave rules.
Wait for a turn if you are going long, if short. I wouldn't look at entering just yet, you could catch a falling knife.
Big DROP in USD with BTC dip today. Seems like people are dumping alts for BTC in an act of desperation fomo right now.
Possible Wave Failure On ETH
Need to be careful here, possible wave failure on ETH is likely if this 4th wave keeps on going, it will ignore the Elliot Wave rules.
Wait for a turn if you are going long, if short. I wouldn't look at entering just yet, you could catch a falling knife.
Big DROP in USD with BTC dip today. Seems like people are dumping alts for BTC in an act of desperation fomo right now.
XRP Retracement Due?
XRP still has not completed a retracement bounce from the previous drop over the last few weeks. We could see a shoot up from this zone and possibly hit the 44-45 cents range.
Fuelled by possible rumours with American Express we would expect some fomo buying so be careful.
But technicals are showing that XRP has only retraced a small amount of the drop so far and has some more to go.
XRP Retracement Due?
XRP still has not completed a retracement bounce from the previous drop over the last few weeks. We could see a shoot up from this zone and possibly hit the 44-45 cents range.
Fuelled by possible rumours with American Express we would expect some fomo buying so be careful.
But technicals are showing that XRP has only retraced a small amount of the drop so far and has some more to go.
ETH Broke Out Finally Worth Talking About
Been mentioning this for a while now. ETH and the little area it has been stuck in. Finally broken out.
To the people who bought over the last few days, well done. Please ensure your stop-losses are adjusted into profit and manage that position.
Please ensure you wait for support to be found for an entry into a long position. This could fall back down. Support has to be found on the higher timeframes using a trusted area of support ( EMA 34 or Fib/Pivot)
We expect this to go from strength to strength over the course of 2019. But this is short term.
ETH Broke Out Finally Worth Talking About
Been mentioning this for a while now. ETH and the little area it has been stuck in. Finally broken out.
To the people who bought over the last few days, well done. Please ensure your stop-losses are adjusted into profit and manage that position.
Please ensure you wait for support to be found for an entry into a long position. This could fall back down. Support has to be found on the higher timeframes using a trusted area of support ( EMA 34 or Fib/Pivot)
We expect this to go from strength to strength over the course of 2019. But this is short term.
IMTL is our new low float subpenny alert.New Partnership w/KODAK
========================
IMTL (Image Protect Inc.)
Alert Price: $0.0042
Float: 134M
Chart Analysis
Corporate Video
Investor Presentation
CEO Interview
Website | Recent News
========================
Members,
We're kicking off this fresh week of trading with an exciting subpenny alert with triple-digit gain potential.
Please turn your immediate attention to IMTL (Image Protect Inc.).
As many of you know already, we love these low-float, subpenny picks, because even the slightest move in share price can result in monster gains for traders.
Our latest alert IMTL , is showing us all the signs of a company that could breakout for monster gains in a very short amount of time.
On Tuesday, IMTL dropped huge news that we believe the market hasn't had a chance to react to yet.
The Company announced the formation and signing of a strategic partnership agreement (the “Partnership”) with RYDE Holding (“RYDE”), the creator and operator of the KODAKOne Image Rights Management Platform.
The two companies believe the Partnership will generate over $5 million in digital image copyright infringement claims and drive tangible revenue growth starting in calendar Q3 2019.
This is the type of news that could send shares of this low-float, subpenny alert soaring in no time at all!
The Bullish Case for IMTL
This global leader in the end-to-end copyright infringement sector has/is:
Just $1.2M worth of shares available for trading, so you can expect a huge move from it on tomorrow's anticipated jump in share volume .
Operating in a rapidly growing image ad market expected by notable analysts to reach $400 Billion by 2025.
On schedule to launch Fotofy on August 1st, Fotofy is the Industry’s only Image Market Place, where-in Users and Rightsholders get paid through a streamlined In-Image Marketing program.
Trading on a bottom'd out chart, near its 52-week low (Major Bounce Opportunity)
Upside of over +733%!
We don't think IMTL is going to be a subpenny stock for much longer.
In fact, if IMTL were to rally back to $0.01, traders would see gains of over +138%!
In our opinion, the upside for IMTL is just too good to ignore.
That being said,we ask that you start your research now, and consider building a position in IMTL tomorrow morning at 9:30AM EST!
About Image Protect Inc.
Image Protect Inc. (OTC: IMTL ) (imageprotect.com) protects and monetizes creative works. By uniting technology with a team of copyright experts, they ensure that content providers preserve the value of their digital assets. Their web application monitors the global Internet to seek and collect evidence for illegally used visual content. Then their legal partners across North America, Europe, and Asia ensure their clients receive appropriate compensation for work used without valid license.
IMTL By the Numbers:
30 Media Agencies Onboard
300K Independent Photographers
4.5M Images Currently Monitored
20+ International IP Legal Partners
Revenue Model
Subscription-based model for individual photographers
End-to-end tracking and recovery model for individual photographers and large media agencies
Subscription tracking only model for photo agencies ad brands
Copyright registration model
IMTL is Ready to Change the Photo Industry with Fotofy
The evolution of Fotofy technology brings the Company to the threshold of an entirely new and disruptive approach to the Photo industry. IMTL will unveil the Industry’s only Image Market Place, where-in Users and Rightsholders get paid through a streamlined In-Image Marketing program. This uniquely positions management to further capitalize by moving into this rapidly growing market expected by notable analysts to reach $400 Billion by 2025.
Click here to see how Fotofy is going to change the photo industry forever
The Fotofy launch is on schedule, and is set to go live on August 1!
The news of this upcoming product launch has us extremely bullish on IMTL .
Image Protect Partners with MadHive To Monetize IPShare™ in $105B Ad-Tech Space
IMTL formed a strategic partnership with MadHive (madhive.com), a leading blockchain-driven data management platform in the ad-tech marketplace that served over 3 billion ad impressions in 2018. The partnership is predicated on the objective of exploring, defining, and deploying a monetization strategy for the Company’s powerful IPShare™ technology as a programmatic digital advertising model.
“We believe the future of technology is decentralized,” said Adam Helfgott, CEO of MadHive. “We are building the 'pipes' for a decentralized ad network, and Image Protect is building something special within our network.”
According to recent MAGNA Group research, the advertising industry hit a record $552 billion in global sales in 2018, which represents an increase of 7.2% on a year-over-year basis. Digital advertising accounts for 35% of the overall market. But consumer research suggests this share could increase dramatically over coming years, with blockchain technology representing a powerful avenue for this transition. According to research from Zenith, “Digital is driving virtually all growth in the global ad market.”
Management notes that MadHive has a proven track record in leveraging blockchain technology for the authentication of “true value transactions” in the ad-tech ecosystem without sacrificing either transparency or efficiency. The Company believes that this will help to establish a clear path to monetizing the IPShare™ model given the accuracy and exchange efficiency of both ad impressions and data analytics within the MadHive platform.
“We are currently testing 2.5 million images, including the monetization of dormant images,” noted Matthew Goldman, Image Protect CO-CEO. “Once testing has been completed, MadHive will collaborate with digital advertising agencies to utilize these images as digital billboards.”
Management believes that its IPShare™ model will deliver an empowering AD-Technology solution to mainstream digital image rightsholders and content creators, leveraging the power of to manage digital licenses, in-photo advertisements, and revolutionary user analytics for tracking, protecting, and monetizing the digital life of proprietary content.
Encouraging rightsholders to join the Image Protect platform has been easier than ever – which is exciting, because it means the past four years of hard work is finally starting to pay off . “IPShare™ is changing the way people can market online. Pictures converted to the IPShare™ format can be embedded with advertisements – think YouTube and Facebook ads, but in picture format. Content owners immediately see the value and are thrilled to become a part of the Image Protect team.”
ICOx Innovations Client RYDE Holding Inc. Signs Partnership Agreement With Image Protect That Is Expected to Generate a Significant Amount in Infringement Claims
The partnership will integrate Image Protect’s License Recovery Unit with RYDE Holding’s KODAKOne platform which will add thousands of new copyright infringement cases and numerous new digital rights holder clients to the KODAKOne platform. Additionally, this integration will generate a significant amount in infringement claims starting within the next two months.
"This is very exciting news for ICOx Innovations’ client RYDE Holding Inc. This collaboration will result in increases across the board in use cases, new clients and revenues, in addition to extending global services. This is the first in many great partnerships.” noted ICOx Innovations President, Bruce Elliott .
Jan Denecke, CEO of RYDE Holding said “We are very excited about our partnership with Image Protect. Together, we will continue to help protect digital storytellers worldwide. Additional cases provided by Image Protect ultimately compliment and fortify our presence in North America, Europe and SE Asia.”
Matthew Goldman, CEO Image Protect noted, “Through KODAKOne’s global post-licensing service we now extend our service offer to our clients by additionally recovering licenses from new markets such as Europe and SE Asia. This integration provides an opportunity for both the companies to generate and share untapped image infringement claims that will benefit both the companies by generating significant additional revenues.”
The RYDE and Image Protect partnership will be implemented over the coming quarter, with infringement identification, fee collections and revenues targeted to commence in August 2019.
Recent Developments:
Image Protect Partners with KODAKOne in Deal Expected to Generate Over $5M in Digital Image Rights Revenues
Last Wednesday, IMTL announced the formation and signing of a strategic partnership agreement (the “Partnership”) with RYDE Holding (“RYDE”), the creator and operator of the KODAKOne Image Rights Management Platform.
The two companies believe the Partnership will generate over $5 million in digital image copyright infringement claims and drive tangible revenue growth starting in calendar Q3 2019.
A Media Snippet accompanying this announcement is available by clicking on the image or link below:
Image Protect Snippet: Image Protect Partners with KODAKOne in Deal Expected to Generate Over $5M in Digital Image Rights Revenues
Matthew Goldmann, CEO Image Protect noted, "Through KODAKOne’s global post-licensing service we now extend our service offer to our clients by additionally recovering licenses from new markets such as Europe and SE Asia. This integration provides an opportunity to generate and share untapped image infringement claims that will benefit both companies by generating significant additional revenues. This will enable Image Protect to continue to scale at unprecedented rates."
The partnership will integrate Image Protect's License Recovery Unit with RYDE Holding's KODAKOne platform, creating an overlap that will bring the KODAKOne platform to bear on thousands of new copyright infringement cases and numerous new digital rightsholder clients.
The two companies believe that this integration will position the Partnership in a market-leading role in the digital image rights protection space as the overall cloud-based digital rights management market continues to grow from $491.5 million in 2016 to just over $2.5 billion by 2025 (according to a ResearchNReports study).
RYDE CEO , Jan Denecke, said, "We are very excited about our partnership with Image Protect. Together, we will continue to help protect digital storytellers worldwide. Additional cases provided by Image Protect ultimately compliment and fortify our presence in North America, Europe and SE Asia.”
The Partnership will be implemented over the coming quarter, with infringement identification, settlements, and revenues targeted to commence immediately.
Market Outlook:
CNBC Report Reveals Digital Ad Revenue Experienced 21.8% Boost in 2018, Eclipsing 2017 Revenues of $88.3 Billion
According to a CNBC.com report, digital ad growth has bolstered over $100 Billion from advertisers seeking massive audiences and targeting tech giants like Google and Facebook .
“The momentum behind this paradigm shift represents a tremendous opportunity for our Company, Rightsholders, and shareholders,” stated Matthew Goldman, Image Protect Co-CEO. “It’s not often when timing and opportunity meet simultaneously. In consideration of our launch in the industry, we firmly believe that the window of opportunity is now.” He concluded: “Standing on the threshold of a revolutionized industry, we view our growth potential to be considerably higher than we’ve ever experienced with the Copyright model.”
The new report states internet advertising revenues in the U.S. totaled $107.5 billion for full-year 2018 — the first time that figure has topped $100 billion. The report, commissioned by the Interactive Advertising Bureau ( IAB ) and conducted by PwC, said revenue in 2018 was 21.8% higher than full-year 2017 revenue of $88.3 billion. That double-digit growth in internet advertising comes as TV advertising increased 1.4% and radio grew 1% from 2017 to 2018, according to the report. Meanwhile, newspaper advertising decreased 6.9% and magazine advertising fell 2.1% in 2018 year over year.
An in-depth research report released last month forecasted the global growth of the native advertising market to 2025. Analysis of overall digital ad spend growth, combined with native advertising trends per market, globally, has revealed that native advertising spend is expected to increase by 372% from 2020 to 2025.
This represents an increase in the native advertising market from $85.83Bn in 2020 to a total global value of $402Bn by 2025. Image Protect stands uniquely positioned to immerse itself into this growing Industry by way of its extensive experience in the Photo Industry.
Technical Analysis:
We love these low-float, subpenny picks, because even the slightest move in share price can result in monster gains for traders.
IMTL has a well recorded history of showing traders some highly profitable intraday swings.
It is also trading just slightly above its 52-week low, which leads us to believe that its upside potential far outweighs its downside risk.
In fact, a run back to its 52-week high of $0.035 from today's alert price would net traders over +733% in pure profit!
We've done our very own chart analysis, and see the potential for a move of +161%!
The Bottom Line
As we stated above, we don't think IMTL is going to be a subpenny stock for much longer.
The Company is operating in a multi-billion dollar sector, and is set to launch game changing technology in just a few weeks on August 1st.
This could be one of your last chances to grab up shares for under a penny.
That being said, we ask that all members start their research on IMTL immediately, and consider building a position tomorrow morning at 9:30AM EST
(*Remember to use a Basic Stop-Loss Order or more advanced Stop Limit Order to protect your gains, as well as limit possible losses.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated fifteen thousand dollars by ACN LLC for a 1-day investor relations advertising marketing campaign w/ 1000 TradingView™ views for IMTL . We have been previously compensated ten thousand dollars by ACN LLC to conduct investor relations advertising and marketing for IMTL-which has expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
LTC Getting Towards Retest Of Resistance
With Litecoin halving fast approaching it may find it having one last pop.
Bitcoin is key for the USD growth at the moment, industry wise. With the BTC value in coins (LTC/BTC) falling fast, the USD value is holding well due to the strength of BTC .
IF BTC retests highs again, you may find LTC go with it but further decline in the BTC value of your LTC holding.
This is important you know what method of entry you go for, BTC or USD.
LTC Getting Towards Retest Of Resistance
With Litecoin halving fast approaching it may find it having one last pop.
Bitcoin is key for the USD growth at the moment, industry wise. With the BTC value in coins (LTC/BTC) falling fast, the USD value is holding well due to the strength of BTC .
IF BTC retests highs again, you may find LTC go with it but further decline in the BTC value of your LTC holding.
This is important you know what method of entry you go for, BTC or USD.
XRP Rumours - Can it fuel a retest to 50c ranges?
This one is a risky one but whenever I look at Twitter or Telegram channels I am constantly seeing XRP with numbers of banking partnerships and what the benefits of MoneyGram will be.
It feels like XRP is being weighed down and it will eventually move up. So much Fundamental news and developments have come out over the last few months yet, it's not shown that in the price. We feel it is only a matter of time that something happens.
Maybe when BTC dominance slows down, growth will be seen in alts, and you can bet XRP will bring a lot of buyers to it.
XRP Rumours - Can it fuel a retest to 50c ranges?
This one is a risky one but whenever I look at Twitter or Telegram channels I am constantly seeing XRP with numbers of banking partnerships and what the benefits of MoneyGram will be.
It feels like XRP is being weighed down and it will eventually move up. So much Fundamental news and developments have come out over the last few months yet, it's not shown that in the price. We feel it is only a matter of time that something happens.
Maybe when BTC dominance slows down, growth will be seen in alts, and you can bet XRP will bring a lot of buyers to it.